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General introducti on
8 Chapter 1
This thesis reports on studies investigating different phases of stepped care for chronic 
fatigue syndrome (CFS). The studies are aimed to gain insight into the process of diagnosing 
CFS by a general practitioner, to test the effectiveness of implementation of different 
elements of stepped care and to indentify moderators of treatment response of the first 
step of stepped care, guided self-instruction. The overall purpose of these studies is to 
develop strategies to increase treatment capacity and treatment efficiency for patients with 
CFS. In this introduction, stepped care for CFS and the objectives for the different studies 
are described. 
Chronic Fatigue Syndrome
Fatigue is a sensation that is hard to define. Everyone feels tired from time to time. It is 
a part of everyday life. However, fatigue can become a problem and interfere with daily 
life. Research shows that 25-30% of the complaints in general practice are fatigue related. 
In the general population these percentages are even higher, 30-50% report fatigue as a 
symptom [1-7]. In Dutch general practice, fatigue is found to be the third most common 
complaint [8]. Approximately 5-10% of the patients in primary care describe fatigue as their 
main complaint [9]. When fatigue becomes severe, lasts longer than six months, is medically 
unexplained, and leads to substantial impairments in daily life, a general practitioner can 
consider the diagnosis CFS. Chronic fatigue is defined as self-reported physical and/or mental 
discomfort during a period for at least six months which expresses itself in exhaustion, due 
to which a person is physically and/or mentally unable to function on the required level 
[10]. To fulfil the United States Centers for Disease Control and Prevention criteria (CDC) 
for CFS patients must report, aside from fatigue and disabilities, four out of eight additional 
symptoms: unrefreshing sleep, post-exertional malaise, headache, muscle pain, multi-joint 
pain, sore throat, tender lymph nodes and concentration and memory impairment [11]. In 
the Netherlands, it is estimated that there are 30 000 to 40 000 patients with CFS [12]. A 
recently published study suggests that there are even more people with CFS. They estimate 
that 1% of the general population, i.e., 128 500 adults, in the Netherlands meet the CDC 
criteria for CFS [13]. 
Diagnosing CFS
General practitioners are able to diagnose CFS. However, knowledge about how to diagnose 
CFS is limited among general practitioners and negative attitudes towards CFS exist, 
preventing it from being diagnosed [14, 15]. Not diagnosing CFS causes harm as there are 
effective treatments for CFS. Spontaneous recovery of CFS occurs in only 5% of the patients 
[16]. Therefore, effective management of CFS is only possible if general practitioners 
are able to diagnose CFS, resulting in an accurate referral for treatment. Scheeres et al. 
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evaluated the impact of informational interventions on general practitioners referrals of CFS 
patients [17]. They found that repeated written information about CFS had a clear impact 
on referral behaviour. General practitioners who had read the information reported that 
they had better knowledge about CFS and had a more positive attitude towards diagnosing 
CFS. Although providing information increased the number of referrals for treatment for 
CFS—based on data of the Dutch Health Council—the number of CFS patients living in the 
region was estimated five times higher than the actual number of patients that was referred 
to the mental health centre (MHC) [12, 18]. A study investigating the prevalence of fatigue—
based on the data of the Nijmegen Biomedical Study—reported that of the patients fulfilling 
the criteria for CFS, only 6.7% (6 out of 89) was diagnosed as having CFS [13]. Both studies 
implicate that general practitioners’ knowledge about how and when to diagnose CFS is 
limited [13, 17]. This suggests that correctly diagnosing CFS—which enables a referral for 
treatment—is necessary to improve the prognosis of CFS patients.
Cognitive Behaviour Therapy is effective 
Systematic reviews of treatments for CFS, including behavioural, pharmacological, and 
complementary approaches conclude that cognitive behaviour therapy (CBT) is an effective 
approach. CBT for CFS leads to significant improvement of fatigue and impairments in CFS 
patients [19-22]. Some patients even fully recover [23].
CBT is aimed at the perpetuating cognitive and behavioural factors of CFS. Perpetuating 
factors are factors that maintain fatigue. In CBT for CFS the focus lies on changing 
dysfunctional fatigue related cognitions and in gradually increasing daily activities. The 
treatment protocol used by our tertiary treatment centre, the Nijmegen Expert Centre for 
Chronic Fatigue, is based on the model of perpetuating factors introduced by Vercoulen et 
al. [24]. The model assumes that the belief that symptoms have a physical cause can lead to 
a reduction of physical activity, which results in the perpetuation of fatigue and disabilities. 
Also a lower sense of control over symptoms, also called self-efficacy, and a strong focus on 
bodily symptoms can perpetuate fatigue and impairments. A later study showed that a lack 
of social support had a negative influence on the level of fatigue [25] (Figure 1). The efficacy 
of CBT for CFS—based on this model—is demonstrated in several trials [23, 26-28].
Treatment protocol of CBT for CFS
The aim of CBT for CFS is reducing fatigue and disabilities by changing fatigue-related 
cognitions and behaviours. CBT for CFS starts with the establishment of goals and explaining 
the model of perpetuating factors to the patient. When formulating the treatment goals, 
it is explained to the patient that recovery is possible. Recovery means that a patient no 
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Figure 1: Model of perpetuating cognitions and behaviour of CFS
longer suffers from CFS, in other words: is no longer severely fatigued and disabled, and 
can resume ‘normal’ activities as a result of the therapy. At the start of CBT, recovery 
will be defined in concrete behavioural terms leading to concrete treatment goals. Next, 
fatigue related cognitions are changed. Patients are helped to reduce the focus on bodily 
symptoms and to develop a sense of control over their symptoms. In addition, patients start 
to regulate their sleep-wake cycle and learn how to divide their activities more evenly over 
the day. After this, patients start with a graded activity program consisting of walking or 
cycling. Patients with low physical activity levels do not have to divide their activities first, 
they immediately start with a build up of their activity level. Through this graded activity 
program, dysfunctional illness beliefs, e.g. the thought that activity will increase the severity 
of fatigue, are challenged, while avoidance behaviour is reduced. Supplementary, patients 
learn how to deal with the reaction of their social environment regarding their symptoms 
and to increase mental and social activities. By gradually increasing their activities, patients 
will experience more sense of control over their symptoms. Once patients have increased 
their activities to an adequate level, they start to systematically accomplish their personal 
goals as set at the beginning of the therapy. The treatment ends with interventions aimed 
at the prevention of relapses.
Social support
FATIGUE
Focus on bodily 
symptoms
IMPAIRMENT
Physical
activity
Somatic 
attributions
Sense of control
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Stepped care for CFS: less is more
longer suffers from CFS, in other words: is no longer severely fatigued and disabled, and 
can resume ‘normal’ activities as a result of the therapy. At the start of CBT, recovery 
will be defined in concrete behavioural terms leading to concrete treatment goals. Next, 
fatigue related cognitions are changed. Patients are helped to reduce the focus on bodily 
symptoms and to develop a sense of control over their symptoms. In addition, patients start 
to regulate their sleep-wake cycle and learn how to divide their activities more evenly over 
the day. After this, patients start with a graded activity program consisting of walking or 
cycling. Patients with low physical activity levels do not have to divide their activities first, 
they immediately start with a build up of their activity level. Through this graded activity 
program, dysfunctional illness beliefs, e.g. the thought that activity will increase the severity 
of fatigue, are challenged, while avoidance behaviour is reduced. Supplementary, patients 
learn how to deal with the reaction of their social environment regarding their symptoms 
and to increase mental and social activities. By gradually increasing their activities, patients 
will experience more sense of control over their symptoms. Once patients have increased 
their activities to an adequate level, they start to systematically accomplish their personal 
goals as set at the beginning of the therapy. The treatment ends with interventions aimed 
at the prevention of relapses.
Implementation of stepped care for CFS
It has been shown that therapists with no previous clinical experience in treating CFS patients, 
can perform CBT for CFS effectively with training and supervision [27]. This suggests that the 
intervention can be transferred from an academic treatment setting into clinical practice 
settings. As a first step toward nationwide implementation, our centre performed a pilot 
implementation project that took place in an MHC. Results demonstrated that CBT for CFS 
can be successfully implemented in an MHC. Effect sizes for fatigue severity and disabilities 
were within the 95% confidence interval of a statistical benchmark, meaning that the results 
of the pilot implementation were similar as to those found in randomised controlled trials 
testing the effectiveness of CBT for CFS [34]. However, besides training and supervision 
additional actions were necessary for success. This entailed monthly project group meetings 
and the presence of a researcher who performed interventions aimed at the encountered 
problems. On the basis of the gained experiences an implementation manual was developed 
to maximise success of future implementation projects. The underlying idea of this manual 
was that future implementation projects can anticipate at the expected problems and can 
profit optimally from the experiences learned in the past. 
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Outline of the thesis
Implementation of stepped care for CFS is only possible if general practitioners are favourable 
disposed to recognise and diagnose CFS. However, several studies suggest that CFS may be 
under diagnosed in primary care [5, 13, 18]. Chapter 2 describes a study that investigates 
the ability of general practitioners to diagnose CFS in primary care. In a prospective and 
retrospective cohort it is investigated how many patients experiencing fatigue fulfilled the 
criteria for CFS and are diagnosed as such by a general practitioner. 
 
In chapter 3 the effectiveness of a model of stepped care for CFS—guided self-instruction 
followed by additional individual face to face CBT if necessary—is tested. In a randomised 
controlled trial stepped care is compared to care as usual—individual regular face-to-face 
CBT after a waiting period. To gain more insight in the efficiency of stepped care and care as 
usual, the number of individual CBT sessions and the total therapist time required in both 
conditions are compared. This study is undertaken at the Expert Centre for Chronic Fatigue, 
a tertiary treatment centre. 
 
Besides developing stepped care for CFS, treatment capacity can also be enhanced if other 
disciplines instead of fully trained cognitive behavioural therapists are able to deliver the 
treatment. In a randomised controlled trial it is tested whether the minimal intervention 
is also effective when implemented in a community based MHC. Psychiatric nurses, 
unacquainted with CFS and the treatment of CFS, received a short training and supervision 
to support patients during guided self-instruction. The results of the minimal intervention 
on fatigue and impairment in physical functioning and social functioning are reported in 
chapter 4. 
 
Efficiency of guided self-instruction can be further improved if it is known which patients 
are likely to benefit from the minimal intervention. To understand the variability of outcome 
in psychological interventions, moderators of treatment response can be identified. 
Moderators are variables that influence treatment outcome. In chapter 5, first potential 
moderators are selected from the literature. Second—based on the selection—potential 
moderators of treatment response to guided self-instruction are tested.
 
The study presented in chapter 6 evaluates the implementation of CBT for CFS in three 
different MHCs based on the guidelines and experiences as described in the implementation 
manual. One MHC implements CBT for CFS as only intervention, the second MHC implements 
CBT in the context of stepped care for CFS and the third MHC evaluates if effects from an 
earlier implementation of CBT can be sustained. Prior to the start of the implementation the 
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criteria for successful implementation are determined. During project group meetings with 
all those involved, the progress of the implementation is evaluated.
 
Finally chapter 7, entails a general discussion which consists of two parts. In the first part 
of the discussion the practical implications of the findings are discussed. In the second part 
findings are discussed in the context of relevant existing literature on (implementation of) 
treatment for CFS and recommendations for future research are formulated. 
Expert Centre for Chronic Fatigue
The studies reported in this thesis are carried out at the Expert Centre for Chronic Fatigue 
of the Radboud University Nijmegen Medical Centre. Several disciplines, among others 
internists, pediatricians, virologists, oncologists, neurologists, neurophysiologists, 
neuroscientists and psychologists, collaborate to increase the expertise in chronic 
fatigue. Studies focussing on the somatic and psychological factors and consequences of 
CFS resulted in a model of perpetuating factors. This model is the basis of the protocol 
of CBT for CFS [24]. Through the years the model has been refined and improved as well 
as the treatment. Current research focus on nationwide implementation of a model of 
stepped care for CFS, the development of new interventions like internet therapy and 
research into the neurobiological correlates of CFS.
Besides CFS, the Expert Centre for Chronic Fatigue, also performed research on chronic 
fatigue in cancer [35, 36], neuromuscular disorders [37, 38], rheumatoid arthritis [39] 
and other conditions [40-43]. New treatment protocols were developed and adapted 
for disease-specific factors. For example, it has been shown that CBT is effective in 
reducing fatigue in disease-free cancer patients. For more information see the website: 
www.umcn.nl/research/departments/eccf.
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Fatigue is highly prevalent in general practice [1]. Approximately, 5-10% of the patients 
in primary care present fatigue as their main complaint [2]. If this fatigue is medically 
unexplained, prolonged and disabling the diagnosis chronic fatigue syndrome (CFS) can 
be considered. For effective management of CFS, it is necessary to make an accurate—
preferably early—diagnosis, resulting in a suitable referral. Managing the condition will help 
to improve the quality of care for CFS patients [3, 4]. However, CFS is more common in 
primary care than recognised [5]. Although some general practitioners (GPs) are aware of 
the usefulness of the label CFS, other GPs express scepticism and negative attitudes towards 
diagnosing it [6-8]. This study was performed to gain insight in the ability of GPs to diagnose 
CFS.
We performed a prospective and retrospective patient cohort study in a general practice 
group caring for ± 8000 patients. Patients, aged between 18-70 years, visiting the practice 
during the research period (four weeks) and patients who had presented fatigue one year 
ago, were examined to fill out a questionnaire assessing fatigue. Fatigue was measured with 
the Shortened Fatigue Questionnaire [9]. Physical and social disabilities were measured with 
the Medical Outcome Survey Short Form-36 [10]. When patients were chronically fatigued 
and severely disabled, their electronic medical files were examined to exclude alternative 
explanations for their fatigue. Next, a specialist was asked to diagnose each patient as CFS 
or non-CFS. 
Almost 31% of the adult population visiting their GP (n = 500) reported complaints of 
fatigue. Of the patients presenting complaints of fatigue in the past (n = 111), still 50% had 
complaints of fatigue one year later. In the prospective cohort, 2% (18/500) of the patients 
were assumed to fulfil the criteria for CFS based on the United States Centers for Disease 
Control and Prevention. In the retrospective cohort, 8% (19/111) of the patients could be 
classified as having CFS. One person was actually diagnosed by his GP as having CFS.
The results of this study suggest that GPs have difficulties in diagnosing CFS. There is a 
discrepancy between the number of patients that might be considered as having CFS and 
the actual number of patients that is diagnosed with CFS. Although, information is missing 
about the interactions between GPs and patients presenting with fatigue, we conclude that 
this discrepancy is unfavourable. It results in under diagnosis and therefore under treatment 
of CFS in primary care. Based on the information in the electronic medical files, GPs mostly 
interpret fatigue as a symptom of psychosocial problems. They consider the psychosocial 
problem as the central issue and expect that attention limited to the somatic aspects of 
complaints, such as fatigue, hinders the solution of these problems. As there are effective 
21The challenge of diagnosing CFS in primary care
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treatments for CFS, not diagnosing CFS means withholding the patient from the possibility 
to recover. The data emphasise that it is necessary to develop a model of support for GPs, 
which results in an increase in confidence to diagnose CFS. The provision of instruments, 
education and services to diagnose CFS can contribute to this situation.
References
1. Cullen W, Kearney Y, Bury G. Prevalence of fatigue in general practice. Ir J Med Sci. 
2002;171(1):10-2. 
2.  Sharpe M, Wilks D. Fatigue. BMJ. 2002;325(7362):480-3. 
3.  NICE CG 53 Chronic fatigue syndrome/Myalgic encephalomyelitis (or encephalopahty) 
guidline. http://sacfs.asn.au/download/CG53NICEGuideline.pdf (accessed June 
2012). 
4.  Baker R, Shaw EJ. Diagnosis and management of chronic fatigue syndrome or 
myalgic encephalomyelitis (or encephalopathy): summary of NICE guidance. BMJ. 
2007;335(7617):446-8. 
5.  Nijrolder I, van der Windt DA, van der Horst HE. Prognosis of fatigue and functioning 
in primary care: a 1-year follow-up study. Ann Fam Med. 2008;6(6):519-27. 
6.  Bowen J, Pheby D, Charlett A, McNulty C. Chronic Fatigue Syndrome: a survey of GPs’ 
attitudes and knowledge. Fam Pract. 2005;22(4):389-93. 
7.  Steven ID, McGrath B, Qureshi F, Wong C, Chern I, Pearn-Rowe B. General practitioners’ 
beliefs, attitudes and reported actions towards chronic fatigue syndrome. Aust Fam 
Physician. 2000;29(1):80-5. 
8.  Raine R, Carter S, Sensky T, Black N. General practitioners’ perceptions of chronic 
fatigue syndrome and beliefs about its management, compared with irritable bowel 
syndrome: qualitative study. BMJ. 2004;328(7452):1354-7. 
9.  Alberts M, Vercoulen JH, Bleijenberg G. Assessment of fatigue - the practical utility of 
the subjective feeling of fatigue in research and clinical practice. In: Vingerhoets A, 
editor. Assessment in behavioral medicine. London: Routledge; 2001. p. 301-27. 
10.  Stewart AL, Hays RD, Ware JE, Jr. The MOS short-form general health survey. Reliability 
and validity in a patient population. Med Care. 1988;26(7):724-35. 

Eff ecti veness of stepped care 
for chronic fati gue syndrome: 
a randomised 
noninferiority trial
Marcia Tummers
Hans Knoop
Arno van Dam
Gijs Bleijenberg
Journal of Consulti ng and Clinical Psychology 
2010; 78(5): 724-731
24 Chapter 3
Abstract
In this randomised noninferiority study the effectiveness and efficiency of stepped care for 
chronic fatigue syndrome (CFS) was compared to care as usual. Stepped care was formed by 
guided self-instruction followed by cognitive behaviour therapy (CBT) if the patient desired 
it. Care as usual encompassed CBT after a waiting period.
A total of 171 CFS patients were randomly allocated to stepped care or care as usual. Patients 
in both conditions were assessed three times: at baseline, after guided self-instruction, 
or during the waiting period and after CBT. The primary outcome variables were fatigue 
severity (Checklist Individual Strength) and disabilities (Sickness Impact Profile and Medical 
Outcomes Survey Short Form-36).
An intention to treat analysis showed that stepped care (n = 84) for CFS is noninferior to 
care as usual (n = 85). Both conditions were equivalent in reducing fatigue severity, reducing 
disabilities and increasing physical functioning. The treatment results of both conditions were 
in accordance with those of previous randomised controlled trials testing the effectiveness 
of CBT for CFS. The total therapist time needed to treat a patient was significantly less in the 
stepped care condition. 
Stepped care is as effective as CBT and is more time efficient for the therapist.
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Introduction
Chronic fatigue syndrome (CFS) is characterised by severe fatigue that lasts longer than six 
months and leads to functional impairments. It is not the result of an organic disease or 
ongoing exertion and not alleviated by rest [1]. Besides severe fatigue and considerable 
functional impairments, most patients report additional symptoms. According to the CFS 
criteria of the US Centers for Disease Control criteria [1], a patient must report four out of 
eight additional symptoms: unrefreshing sleep, postexertional malaise, headache, muscle 
pain, multi-joint pain, sore throat, tender lymph nodes and concentration and memory 
impairment. 
Cognitive behaviour therapy (CBT) is an evidence-based treatment for CFS [2]. Two recent 
meta-analyses showed that CBT for CFS leads to a reduction in fatigue and disabilities [3-
5]. Besides, The natural course of CFS without treatment is unfavourable; only 5% of the 
patients recover spontaneously [6]. CBT is not only superior to no intervention but is also 
more effective than guided support groups or relaxation training [7, 8]. 
CBT is directed at changing fatigue-related cognitions and behaviours that perpetuate 
fatigue at least to a significant degree. The treatment is aimed at decreasing the focus on 
bodily symptoms, increasing self-efficacy with respect to fatigue, changing the way patients 
communicate about CFS, regulating and/or increasing physical activity, and changing their 
attitude when dealing with the way others react to their symptoms. Recent research has 
shown that CBT is not only effective in randomised controlled trials (RCTs) conducted in 
tertiary university hospitals but can also be successfully implemented in a representative 
clinical practice setting [9]. However, wider implementation is hampered by the fact that 
CBT for CFS is an intensive treatment that requires 13 to 16 sessions, depending on the 
protocol used [7, 10, 11]. Licensed cognitive behaviours therapists need additional training 
and supervision to learn to treat CFS. In addition, the treatment capacity in the Netherlands 
is lacking [12].
It is probable that not all patients need such an intensive treatment as CBT, which would make 
it possible to develop a form of stepped care. In stepped care, more intensive treatments 
are reserved for patients who do not benefit from simpler low-intensity treatments or for 
those who can be predicted not to benefit from such treatments [13]. In the literature, it has 
already been proven that stepped care is effective for psychological interventions [14]. It has 
also been shown that for patients with chronic fatigue, a self-help booklet with support from 
a nurse was more effective than no treatment [15]; a minimal intervention for patients with 
CFS, consisting of psycho-education and a graded activity program, decreased the levels of 
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fatigue and disabilities compared with a control condition [16, 17]. For stepped care for CFS, 
it is necessary to develop a less intensive intervention based on the CBT protocol which can 
be followed by additional CBT.
Recently, we showed in an RCT [18] that a minimal CBT intervention for CFS leads to a 
significant reduction of fatigue and disabilities compared with a waiting list. Twenty-seven 
percent of the patients showed a clinically significant improvement during treatment. 
Instead of 13 to 16 sessions, the minimal intervention consisted of a self-instruction booklet 
based on the CBT protocol for CFS and email contact with a therapist every two weeks. This 
minimal intervention (i.e., guided self-instruction) could be the first step of stepped care, 
followed by additional treatment with individual CBT if the minimal intervention did not 
suffice. If stepped care can be applied in the treatment of CFS patients–which means that 
patients get the intensity of treatment necessary to improve, no more and no less–more CFS 
patients can receive treatment for their condition.
As a second stage of the previously described trial [18], we performed an explanatory 
randomised noninferiority follow-up study in which we offered all patients individual CBT 
after the minimal intervention or waiting list. The main objective of the study was to compare 
the effectiveness of stepped care (self-instruction, possibly followed by additional CBT) to 
care as usual (only regular CBT after a waiting list). In other words, as this is a noninferiority 
trial, we determined whether stepped care was no worse in reducing fatigue and disabilities 
than care as usual. To evaluate the treatment effect of both conditions, outcomes were 
compared with those of previous RCTs testing the effectiveness of CBT for CFS [9].
Furthermore, in an exploratory analysis the efficiency of both conditions was compared. 
First we compared the number of individual CBT sessions, and then we compared the total 
therapist time required in both conditions. During the minimal intervention, patients had 
already received information about their disorder and about the symptom perpetuating 
factors. So, we expected that the informed patient would need fewer sessions of CBT than 
the patients who received CBT for CFS after the waiting list. Therefore, the time a therapist 
needed to deliver stepped care or care as usual could be less in the stepped care condition.
Method
Participants
All patients had participated in the RCT testing the effectiveness of guided self-instruction 
[18]. They were referred for CBT to the Expert Centre for Chronic Fatigue of the Radboud 
University Nijmegen Medical Centre, a tertiary treatment facility. Patients were 18 years 
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or older; spoke and read Dutch; had undergone a medical and psychiatric evaluation that 
excluded other causes of fatigue; fulfilled the US Centers for Disease Control criteria for CFS 
[1]; were severely fatigued, operationalised as scoring 35 or more on the Fatigue Severity of 
the Checklist Individual Strength (CIS) [19]; and were severely disabled, operationalised as 
having a total score of 700 or higher on the Sickness Impact Profile [20]. 
Patients were temporarily excluded from therapy for as long as they were engaged in a legal 
procedure concerning disability-related financial benefits. This was done because a previous 
intervention study had shown that being engaged in such a procedure predicted a negative 
treatment outcome [21] (See Table 1).
Design and procedures
In the original study [18], patients applying for individual CBT were recruited from February 
2006 to September 2007. First, patients received a baseline assessment; when criteria for 
CFS were met, they were offered CBT. Because of limited treatment capacity, patients who
Table 1. Baseline characteristics
Baseline characteristics
Stepped care 
(n = 84)
Care as usual 
(n = 85)
t-value(167) P
Demography
Age, means (SD)
Duration of complaints 
(months, median (min-max))
Male/Female
37.6
72
15
(10.0)
(12,420)
/69
38.5
96
20
(10.6) 
(12,420)
/64
-0.55
-1.22
χ2=0.83
0.58
0.23
0.36
Outcome measures, means (SD)
CIS fatigue severity
SIP total score
SF-36 physical functioning
49.11
659 
52.3
 
(5.2)
(648)
(20.4)
49.9
1515
54.1
(5.6)
(545)
(21.1)
-0.96
 1.56
-0.56
0.34
0.12
0.58
Indices of severity, means (SD)
Number of CDC symptoms 7.1 (1.6) 7.3 (1.6) -0.58 0.57
Perpetuating factors, means (SD)
Activity pattern (passive/active)
Self efficacy
Somatic attributions
Focusing on bodily symptoms
24
17.4
12.4
28.7
/60
(3.2)
(2.9)
(8.1)
20
17.9
12.0
29.6
/65
(2.8)
(3.2)
(8.3)
χ2=0.56
-0.99
 0.86
-0.68
0.46
0.33
0.39
0.50
CIS, Checklist Individual Strength; SIP8, Sickness Impact Profile; SF-36, Medical Outcomes Survey 
Short From-36; CDC, Centers for Disease Control.
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accepted the treatment that was offered were placed on a waiting list (6 to 12 months). 
Patients were then given verbal and written information about the study. They were 
told that while they waited for CBT, they could participate in a study testing the efficacy 
of a minimal intervention, which would not lead to a longer waiting period for individual 
therapy. If informed consent was obtained, patients were randomly allocated to the minimal 
intervention or the waiting list. Allocation to condition was carried out by the therapist using 
cards in consecutive numbered and sealed envelopes that were opened in the presence 
of the patient. An independent statistical advisor prepared the envelopes by coding them 
according to a computer-generated list of random numbers. Randomisation was performed 
in blocks of eight. After the minimal intervention or waiting list, the patient decided whether 
CBT was still desired. Patients in both conditions were assessed three times: (a) at baseline; 
(b) directly following the guided self-instruction or waiting period; and (c) after additional 
CBT (stepped care) or regular CBT (care as usual). When a patient did not want treatment 
after the minimal intervention or waiting period, there were only two assessments: at 
baseline and after the minimal intervention or waiting period.
Intervention
The minimal intervention was based on a published protocol of CBT for CFS [22]. The 
treatment starts with establishing goals and explaining the model of perpetuating factors to 
the patient. Next, fatigue-related cognitions are challenged to diminish somatic attributions, 
to decrease the focus on bodily symptoms, to improve sense of control over symptoms, and 
to facilitate behaviours change. At the same time, a structured physical activity program 
starts. After regulating and/or increasing activity, a work rehabilitation plan or a rehabilitation 
plan in other personal activities was developed. The therapy ends with interventions aimed 
at the prevention of relapses and further improvement of self-control.
In the minimal intervention, patients received a self-instruction booklet with information 
about CFS and assignments. In this booklet the patient could follow the instructions week 
by week. The total program took at least 16 weeks but could take more time if the patient 
wanted to reach goals like resumption of work. The booklet was given to the patient after 
randomisation. The therapist invited the patient to email at least every two weeks, to report 
on the progress and ask questions about the self-instruction. Patients were told that they 
were free to email more frequently if they wanted. If a patient was not able to email, the 
therapist proposed that the patient phone at least every two weeks. After the minimal 
intervention, each patient had a face-to-face session with the therapist to discuss whether 
additional CBT was desirable.
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Regular CBT was delivered according to the protocol described by Bleijenberg et al. [22]. 
The treatment consisted of 14 sessions over a period of six months. The highest attainable 
goal of CBT is recovery, which means (a) no longer being severely fatigued and (b) no longer 
being disabled by the fatigue. In addition, the therapist discussed with the patient whether 
his or her view was no longer that of a CFS patient. This can lead to variation in the number 
of sessions. Both interventions, guided self–instruction and CBT, were carried out by the 
same cognitive behavioural therapists (n = 5). 
In both interventions there were two treatment protocols, depending on the pattern of 
physical activity of the patient. This activity pattern was assessed with an actometer, a 
motion sensing device that can quantify human physical activity. The actometer was worn 
around the ankle during a 14-day period to retain 12 complete registration days. From this 
registration period a relatively active or a passive pattern can be established. A passive CFS 
patient has an average daily activity score below the norm score of CFS patients (norm score 
= 66) on 11 or 12 of a total of 12 days [23]. Patients with a relatively active physical activity 
pattern alternate between periods of activity and periods of rest. These patients have to 
attain a base level of activity, where they spread their activities more evenly over the day. 
After they have achieved this, they gradually increase their activity level and resume work 
and other activities. Patients with a passive activity pattern are continuously physically 
inactive. They immediately start with the graded activity program. Patients with a relatively 
active or passive pattern were evenly grouped between stepped care and care as usual (See 
Table 1).
Outcome measures
Fatigue. Fatigue was measured with the Fatigue Severity subscale of the CIS [19]. This 
subscale indicates fatigue, which is central in CFS patients, over the past two-week period 
with scores ranging between 8 (no fatigue) to 56 (severe fatigue). The CIS is a reliable and 
valid instrument for assessment of fatigue in CFS [24]. 
Disabilities. The level of disability was measured in two ways. The Sickness Impact Profile was 
used to measure functional disability in ambulation, home management, mobility, alertness 
behaviours, sleep and rest, work limitations, social interactions, recreation, and pastimes 
[20]. A weighed total score was computed from the scores on the eight subscales. Physical 
disabilities were measured with the Physical Functioning subscale of the Medical Outcomes 
Survey Short Form-36 (SF-36) [25]. The scores ranged from 0 (maximum limitations) to 100 
(no limitations). 
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Clinically significant improvement. Clinically significant improvement was defined as a 
reliable change index > 1.96 [26] between baseline and post-treatment and a score of < 35 
on the CIS Fatigue Severity subscale at post-treatment assessment. This latter score is within 
two standard deviations of the mean for healthy adults and below two standard deviations 
of the mean for CFS patients [27]. 
Number of therapy sessions. For both conditions, stepped care and care as usual, the 
number of individual CBT sessions was counted (including 2 assessment sessions).
Total therapist time. To compare the efficiency of both conditions, the time therapists needed 
to deliver stepped care and care as usual was calculated. In the stepped care condition, this 
consisted of two assessment sessions of 60 min, the time needed to write emails, and the 
individual CBT sessions (duration = 60 min). The time needed to write emails was calculated 
by counting the number of emails sent by the therapist and multiplying this by the average 
time needed to write one email. For this, the therapists estimated retrospectively the 
mean time they needed to write an email. If patients used the telephone or both email 
and telephone (in case patients did not react on the emails sent by the therapist), or if data 
were missing, it was assumed that this would cost the therapist the same amount of time as 
treating patients who only emailed. In the care as usual condition, the number of individual 
CBT sessions was multiplied by 60 min (including two assessment sessions). If a patient did 
not start treatment, only two assessments sessions were calculated.
Analysis
Analyses were performed using SPSS (version 16) for Windows. Statistical significance was 
assumed at p < .05. The two conditions were regarded as equivalent if the difference in 
CIS fatigue severity (using 95% CI) was less than 5.2 points and there were no significant 
differences on the other two outcome measures, disabilities and physical functioning. The 
boundary of 5.2 points was derived from the 95% CI of the change in CIS fatigue severity 
score that occurred in the waiting list condition in the prior study [18].
To test for differences between the two conditions, an analysis of covariance (ANCOVA) 
was used, with the scores on fatigue severity and level of disabilities directly after CBT as 
dependent variable, the baseline scores as covariate, and the condition as fixed factor (2 
levels: stepped care vs. care as usual). An ANCOVA was used because treatment allocation 
is by randomisation. In this kind of trial, ANCOVA yields greater power than other statistical 
methods [28]. A logistic regression model was used to estimate differences between the 
two conditions in the proportion of patients with a clinical significant improvement of 
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fatigue. All comparisons were performed on the basis of intention to treat. We used multiple 
imputation (using the MICE package) [29] in R (Version 2.9.2) [30] to handle the missing 
observations. In total, 100 imputed datasets were generated. The imputation method used 
was predictive mean matching for all variables with missing data. We used age, condition, 
baseline measurements, measurements after the minimal intervention or waiting period, 
and post-treatment measurements to generate the imputations. The pooling of the results 
was done according to Rubin’s rules [31], using the small sample correction of Barnard and 
Rubin [32]. 
A second logistic regression with condition and baseline CIS fatigue as predictors was used 
to test for differences between (a) only guided self-instruction and stepped care and (b) 
only guided self-instruction and care as usual in the proportion of patients with a clinical 
significant improvement of fatigue. Results of guided self-instruction were adopted from the 
earlier study of Knoop et al. [18].
In a post-hoc analysis, independent sample t tests were used to test for differences at 
baseline in the outcome variables and demographic characteristics between patients who 
either did or did not continue with CBT after guided self-instruction. 
To evaluate the effectiveness of stepped care and care as usual, outcomes were compared 
with those of previous RCTs testing the effectiveness of CBT for CFS. In a statistical benchmark 
[9], we calculated the mean effect size for fatigue severity (CIS; 1.44; 95% CI [0.97-1.89]) and 
physical functioning (SF-36; 1.04 95% CI [0.63-1.44]) of CBT in four RCTs. The pre-post test 
effect size of stepped care and care as usual was calculated ((M start – M end) / SD start) [33] 
and compared to the statistical benchmark. If the effect sizes of a condition fell within the 
95% CI of the mean effect size of the benchmark study for both fatigue severity and physical 
functioning, the condition was considered to meet the benchmark.
Differences in number of CBT sessions and total therapist time for stepped care and care as 
usual were tested with the Student t test and Mann-Whitney U test, respectively. 
 
Results
In the original study [18], 171 patients were randomly allocated to guided self-instruction 
(n = 85) or a waiting list (n = 86). Two patients were excluded because another medical 
condition was diagnosed after randomisation. After the minimal intervention or waiting list, 
all patients were offered CBT. Forty-eight patients of the guided self-instruction condition 
and 19 patients of the waiting list condition declined the offer for further therapy. In the 
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stepped care condition, six patients had no assessment after guided self-instruction, and 
six patients had no assessment after CBT. In the care as usual condition, four patients had 
incomplete data after the waiting period and two after CBT. There were 72 (86%) patients 
with complete data after stepped care and 79 (93%) patients after care as usual (See Figure 1).
Figure 1. Flow of participants through the study
Did not start with cognitive 
behaviour therapy (n = 19)
Waiting list condition (n = 86)
Excluded because of medical explanation for fatigue 
(n = 1)
Intention to treat analysis (n = 85)
Cognitive behaviour therapy (n = 36)
Intention to treat analysis (n = 84)
Completed assessment stepped care (n = 72)
Did not start with guided self-instruction (n = 8/3*)
Guided self-instructions (n = 40/3*)
Guided self-instructions followed by CBT (n=31/5**)
Did not start with guided self-instruction, only CBT 
(n = 5/1**)
/n*= patients without assessment after guided self-
instruction (total = 6)
/n**= patients without assessment after CBT 
(total = 6)
Cognitive behaviour therapy (n = 66)
Intention to treat analysis (n = 85)
Completed assessment care as usual (n = 79)
Did not start with CBT (n = 19/4*)
Cognitive behaviour therapy (n = 66/2**)
/n*= patients without assessment after waiting 
period (total = 4)
/n**= patients without assessment after CBT 
(total = 2)
Did not start with cognitive 
behaviour therapy (n = 19)
Guided self-instruction (n = 85)
Excluded because of medical explanation for fatigue 
(n = 1)
Intention to treat analysis (n = 84)
Randomised (n = 171)
Eligible to enter trial (n = 184)
Original study: Knoop et al.
Current study: Tummers et al.
ST
EP
PE
D
 C
A
R
E
CA
R
E A
S U
SU
A
L
Refused participation (n = 13)
Preferred face-to-face contact (n = 8)
Reason for refusal unknown (n = 5)
33Effectiveness of stepped care for CFS: a randomised noninferiority trial
3
Comparison of the effectiveness 
The difference in fatigue severity between the two groups was 0.2 (95% CI [-3.9 to 
4.4]). On the basis of the analyses, stepped care was declared noninferior to care as 
usual because the upper bound of the 95% CI (4.4) was within the critical interval 
for determining noninferiority (+5.2). There were no significant differences between 
stepped care and care as usual for fatigue severity, disabilities and physical functioning 
(See Table 2). The logistic regression showed that there were no significant differences 
between stepped care and care as usual for clinically significant improvement in fatigue 
at the post-treatment assessment (See Table 3).
The second logistic regression showed that after guided self-instruction, the proportion 
of patients with a clinical significant improvement was significantly smaller compared to 
stepped care, β = 0.39, χ2 (2, n = 168) <0.01, and care as usual, β = 0.35, χ2 (2, n = 169) 
<0.01.
Comparisons of post-hoc analysis 
Table 4 describes baseline demographic characteristics and outcome measures for 
the patients who either did or did not continue with CBT after guided self-instruction. 
There were no significant differences between those two groups for age, gender, fatigue 
severity, and physical functioning. Patients who continued with CBT after guided self-
instruction reported significantly more disabilities ( p < .01) at the baseline measurement 
(See Table 4). 
Effect size 
The effect size for stepped care was 1.37 for fatigue severity and 0.88 for physical 
functioning. For care as usual this was 1.42 and 0.70, respectively. Both effect sizes are 
within the 95% CI of the benchmark. 
Comparison of the number CBT sessions 
After guided self-instruction, patients (n = 36) needed a mean of 10.9 CBT sessions, 
compared with 14.5 sessions in the care as usual condition (n = 66, p < .01; see Table 5).
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Comparison of the total therapist time
Of the 84 patients in the stepped care condition, 70 patients had contact with their therapist; 
55 (66%) emailed, five (6%) used the telephone exclusively, and 10 (12%) used both email 
and telephone. The remaining 14 (17%) patients did not contact the therapist, 13 of them 
did not start with the guided self-instruction, and one completed the program without 
assistance of a therapist [18]. For two patients the number of emails sent by the therapist 
were missing. In these cases, the mean number of emails sent by all therapists was filled 
in. The same was done for patients who exclusively used the telephone or used email and 
telephone to contact their therapist. The therapists sent a mean of 8.9 (SD = 6.4) emails per 
patient and spent a mean of 22 min (range: 15-30) writing an email. Taking the number of 
CBT session into account, the total therapist time needed per patient was significantly lower 
in the stepped care condition (median = 420 min) compared to care as usual (median = 720 
min, p = .01; See Table 6). 
Table 3. Comparison of Proportion of Clinical Significant Improvement in CIS fatigue 
Severity Between  Conditions
Outcome measure
Stepped care 
(n = 84)
Care as usual 
(n = 85)
OR (95% CI) t-value(153) P
CIS fatigue severity, 
proportion %
41/84 (49%) 41/85 (48%)
1.00
(0.53 to 1.89)
0.00 1.00
CIS, Checklist Individual Strength; OR, odds ratio; CI, confidence interval.
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Table 5. Number of Therapy Sessions 
Outcome measure
Stepped care 
(n = 36)
Care as usual 
(n = 66)
t-value(100) P
Number of therapy 
sessions during CBT 
(mean; SD)*
10.9 (4.4) 14.5 (5.3) -3.4 <0.01
* Including 2 assessment sessions
Table 6. Total Therapist Time 
Outcome measure
Stepped care 
(n = 84)
Care as usual 
(n = 85)
u-value(100) P
Therapist time in
minutes 
(median; min-max)*
420 (120 – 1440) 720 (120 – 2040) -2.4 0.01
* Including 2 assessment sessions
Table 4. Post-hoc Analysis of Baseline Outcome Measures 
Baseline 
characteristics
No CBT after 
guided self-
instruction 
(n = 48)
CBT after 
guided self-
instruction
(n = 36)
t-value(82) P
Demography
Age
Male/Female
37.8
7
(9.5)
/41
37.0
8
(10.8)
/28
 -0.38
χ2=0.82
  0.71
  0.37
Outcome measures
CIS fatigue severity
SIP total score
SF-36 physical 
functioning
48.1
1483
54.1
(4.9)
(948)
(21.4)
50.3
1893
50.0
(5.3)
(578)
(19.1)
 1.93
 3.05
-0.92
  0.06
<0.01
  0.37
CIS, Checklist Individual Strength; SIP8, Sickness Impact Profile; SF-36, Medical Outcomes Survey 
Short From-36.
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Discussion
This study showed that stepped care for CFS was statistically equivalent to care as usual in 
reducing fatigue severity and level of disabilities and increasing physical functioning. The 
results indicate that stepped care is noninferior to care as usual, as the upper limit of the 
95% CI for the difference between stepped care and care as usual was 4.4 (boundary was 
5.2). The treatment results of stepped care and care as usual are in accordance with those 
of previous RCTs testing the effectiveness of CBT for CFS [9]. We infer from the fact that the 
percentage of subjects with clinically significant improvement after guided self-instruction 
(27%) [18], is considerably less than after stepped care (49%, p < .01), that it is possible to 
profit from additional CBT after the minimal intervention. When guided self-instruction was 
not sufficient, fewer sessions of CBT were required in subsequent treatment. This suggests 
that if the minimal intervention does not lead to (sufficient) reduction of symptoms, it does 
prepare patients for subsequent CBT. Finally, therapists needed less time to treat a patient 
in the stepped care condition compared with care as usual, indicating that stepped care is 
more time efficient for therapists. 
A limitation of this study is the fact that a waiting period preceded CBT in the care as usual 
condition. Powell et al. [16] found that a delay in treatment of CFS patients is associated 
with reduced efficacy. However, this does not seem to be the case in the present study, as 
the effect size of care as usual corresponded with the statistical benchmark [9]. 
Patients were offered additional treatment after the minimal intervention or regular CBT 
after the waiting period, regardless of the current level of complaints. In a session with 
their therapist, patients decided whether (additional) CBT was desirable. After guided self-
instruction, 48 patients declined the offer for additional CBT. Nineteen patients did not want 
regular CBT after the waiting period. When a patient decided not to receive further treatment 
only two assessments were available: the baseline assessment and the assessment after 
guided self-instruction or the waiting list. Therefore, the period between baseline and post-
treatment assessment could show large variability. 
We did not test the treatment integrity of guided self-instruction and CBT. However, the 
five therapists who delivered both treatments were all well trained and experienced in 
delivering CBT for CFS. Therapists were supervised once every two weeks throughout the 
trial. The fact that the treatment results of both conditions, stepped care and care as usual, 
are in accordance with other trials supports the assumption that both interventions, guided 
self-instruction and CBT, were of good quality. 
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The calculation of the time spent by the therapist could be criticised. The mean time therapists 
needed to write an email was asked retrospectively and is therefore only an estimation of 
the actual time spent by the therapist. Furthermore, no data were available when patients 
used the telephone during the minimal intervention. It could be that communicating with 
patients by telephone takes more therapist time. This might have led to an underestimation 
of the therapist time per treated patient, making stepped care seem more time efficient 
than it is.
Finally, in our study qualified cognitive behavioural therapists, all of whom were psychologists 
working in a specialist centre, delivered the interventions. In the Netherlands, CBT is 
delivered by cognitive behavioural therapists. Whether other health care professionals−for 
example, psychiatric nurses with fewer psychotherapeutic qualifications−would be able to 
effectively guide CFS patients is unknown. If this were possible, it would probably lower the 
costs of stepped care. Therefore, in a current trial we are testing the effect of the minimal 
CBT intervention delivered by nurses.
To our knowledge, this is the first time the effectiveness of stepped care for CFS has been 
evaluated. The results showed that stepped care for CFS is as effective as care as usual, but 
is more time efficient. Stepped care makes it possible to increase the available treatment 
capacity, while providing an intervention more tailored to the needs of the individual patient. 
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Abstract
Cognitive behaviour therapy (CBT) for chronic fatigue syndrome (CFS) is an effective but 
intensive treatment, requiring trained therapists. A minimal intervention based on CBT for 
CFS, guided self-instruction, was shown to be an effective treatment when delivered in a 
tertiary treatment centre. Implementing this intervention in a community-based mental 
health centre (MHC) will increase the treatment capacity for CFS patients. This study 
evaluated the effectiveness of guided self-instruction for CFS implemented in an MHC, 
delivered by nurses.
One hundred and twenty-three patients were randomly assigned to either guided self–
instruction (n = 61). Randomisation was computer generated, with allocation by numbered 
sealed envelopes. Group allocation was open to all those involved. Patients fulfilled 
US Centers for Disease Control and Prevention (CDC) criteria for CFS. Primary outcome 
variables were fatigue severity and physical and social functioning, measured with the 
Checklist Individual Strength (CIS) and the Medical Outcomes Survey Short Form-36 (SF-36) 
respectively.
After six months, patients who followed guided self-instruction reported a significantly 
larger decrease in fatigue compared to the waiting list (mean difference -8.1 95% confidence 
interval (CI) -3.8 to -12.4, controlled effect size 0.70). There was no significant difference in 
physical and social functioning. However, post-hoc analyses showed a significant decrease 
in fatigue and physical disabilities following the intervention in a subgroup of patients with 
physical disabilities at baseline (SF-36 physical functioning ≤70).
Implementation of guided self-instruction in a community-based MHC was partially 
successful. The minimal intervention can be effectively implemented for CFS patients with 
physical impairments.
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Introduction
Patients with chronic fatigue syndrome (CFS) have severe fatigue lasting longer than six 
months. The fatigue is not the result of a known organic disease or ongoing exertion, not 
alleviated by rest and leads to substantial functional impairment [1, 2]. Several systematic 
reviews and controlled trials have shown that cognitive behaviour therapy (CBT) leads to a 
significant reduction in symptoms and disabilities in patients with CFS [3-5]. CBT is aimed at 
cognitions and behaviours assumed to perpetuate the fatigue. It is a safe treatment and a 
subgroup of patients fully recovers [5-7].
CBT for CFS is an intensive treatment, with 13-16 sessions depending on the protocol used 
[8-11]. There is evidence that not all patients need such intensive treatment. Knoop et al. 
[12] showed, in a randomised controlled trial (RCT), that a minimal intervention for CFS, 
guided self-instruction, leads to a significant decrease in fatigue and disabilities. For a 
subgroup of patients, the minimal intervention sufficed. If the minimal intervention was 
not successful, patients needed substantially fewer sessions of additional CBT, compared to 
patients who were referred directly for regular CBT [13]. The minimal intervention consisted 
of a booklet with instructions, based on the protocol of CBT for CFS, and two-weekly email 
contact with a therapist. 
Guided self-instruction was delivered at a tertiary university hospital with guidance of 
qualified cognitive behavioural therapists, who had extensive experience in treating patients 
with CBT for CFS. In the Netherlands, there is a lack of treatment capacity for patients with 
CFS [14]. To increase treatment capacity it is necessary to offer evidence-based treatments 
for CFS outside specialised treatment settings. The objective of this study was to test 
whether the minimal intervention was also effective when delivered at a community-based 
mental health centre (MHC). An MHC in the southwest of the Netherlands was chosen as 
the clinical practice setting. This centre had not previously treated CFS patients. Psychiatric 
nurses, novices with respect to CBT and the treatment of CFS, were trained to deliver the 
minimal intervention. 
Method
Patients
Patients could participate in the study (NTR1223) if they had been referred by a general 
practitioner (GP) or consultant to GGZ WNB, a Dutch regional community-based MHC in 
the southwest of the Netherlands, and were diagnosed as having CFS according to the 
US Centers for Disease Control and Prevention (CDC) criteria [1, 2]. All referred patients, 
aged between 18 and 65, received a baseline assessment. In accordance with the CDC 
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criteria for CFS, patients were eligible to enter the study if they (1) were severely fatigued, 
operationalised as scoring ≥35 on the subscale Fatigue Severity of the Checklist Individual 
Strength (CIS) [15], (2) were fatigued for six months or longer, (3) were severely disabled, 
operationalised as scoring ≤70 on the subscale Physical and/or Social Functioning of the 
Medical Outcomes Survey Short Form-36 (SF-36) [16], and (4) reported at least four out of 
eight additional symptoms; unrefreshing sleep, post-exertional malaise, headache, muscle 
pain, multi-joint pain, sore throat, tender lymph nodes and impairment of concentration or 
memory [1, 2]. The assumption was made that the referring GP or consultant excluded the 
presence of somatic diseases or psychiatric disorders and the use of medication that could 
explain the fatigue.
Design and procedures
The study was an RCT in which the minimal intervention was compared to a waiting list. The 
ethics committee of the Radboud University Nijmegen Medical Centre approved the study. 
Referred patients were contacted by telephone to ascertain that they understood they were 
being referred for a study investigating the effectiveness of a minimal intervention for CFS. 
Patients who were willing to participate were given verbal information and sent written 
information about the study. After written informed consent was obtained, patients were 
requested to complete a set of questionnaires to assess fatigue severity, duration of the 
fatigue, number of CDC symptoms and level of disabilities, and also to gain information on 
medication use and self-reported level of psychopathology, including depressive symptoms. 
If the diagnosis of CFS was doubtful, based on this assessment and/or the referral letter, a 
CFS expert contacted the referring GP or consultant for additional information to evaluate 
whether the diagnosis CFS was justified. Eligibility was examined again during the 30-min 
intake session with the psychiatric nurse, who asked the patient about the presence of 
somatic or psychiatric conditions other than CFS. If they were present, the nurse contacted 
the researcher who informed the CFS expert. If necessary, the expert contacted the GP or 
consultant for additional information. If the diagnosis of CFS could be confirmed, the patient 
was included in the study. Furthermore, psychiatric nurses were instructed to temporarily 
exclude patients who were engaged in a legal procedure concerning disability related 
financial benefits. This was done because a previous intervention study had shown that 
being engaged in such a procedure predicted a negative treatment outcome [17]. During the 
intake session, the nurse who coached the patient during the minimal intervention explained 
the goals of guided self-instruction to the patient. Randomisation took place at the end of 
the session. If a patient was assigned to guided self-introduction, they were advised to stop 
other treatments for fatigue [8].
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To ensure concealed allocation, a statistical advisor, independent of the study, prepared 
numbered and sealed envelopes by coding them according to a computer-generated list of 
random numbers. Randomisation was performed in blocks of six. During the intake session, 
in the presence of the patient, the psychiatric nurse telephoned the researcher, who opened 
the next envelope and stated the condition to which the patient had been assigned. The 
name of the patient was written on the envelope before it was opened, to prevent resealing 
and reusing. Group allocation was open to all those involved. Patients who were allocated 
to the waiting list received the minimal intervention after a delay of six months. Patients 
in both conditions were assessed at baseline and directly following the waiting period or 
intervention. If patients were not willing to fill in all of the questionnaires at the second 
assessment, they were asked to complete only the two questionnaires assessing the primary 
outcome variables.
Intervention
The guided self-instruction consisted of a booklet (58 pages) with information about CFS 
and assignments [12]. Patients could follow the programme, described in the booklet, week 
by week. The intervention was based on the protocol of CBT for CFS and took at least 20 
weeks [18].
 
The first chapter in the booklet challenges patients to establish the goals of the therapy. In 
the following chapters the precipitating (triggering) and perpetuating (maintaining) factors 
are explained and individualised. Fatigue-related cognitions are challenged and patients 
are encouraged to develop a sense of control over their symptoms. In the third chapter 
patients learn to reduce the focus on fatigue. Subsequently, the patients establish a sleep 
routine as described in chapter 4. Chapter 5 explains to patients that there are two different 
physical activity patterns: a relative-active and a low-active activity pattern. Relatively active 
patients, characterised by an alternation of periods of (over)activity and periods of rest, first 
have to learn to divide their activities more evenly (chapter 6). Then they gradually increase 
their physical activity level, by walking or riding a bicycle. Patients with a low-active physical 
activity pattern start immediately with gradually increasing their physical activity level 
(chapter 7). In chapter 8, beliefs that activity would exacerbate symptoms are challenged. 
Chapter 9 invites patients to make a plan for work resumption. This plan contains the date 
when a patient will resume work, and how the patients will increase the number of hours 
worked. The next module is directed at modifying the patients excessive expectations 
regarding the response of their social environment to their symptoms. Often patients 
experience a lack of understanding from others. Patients learn how to communicate about 
CFS. In chapters 11 and 12 patients gradually increase their mental and social activities. 
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In chapter 13, patients attain the goals as formulated in chapter 1 step by step, including 
resumption of work. Finally, in the last two chapters, patients learn how to prevent a relapse 
and how to further improve self-control. 
The booklet was sent to the patients after randomisation. During the intake session, the 
patients who were assigned to the intervention were asked to email once every two 
weeks. This enabled patients to ask questions about the treatment and nurses to monitor 
the progress patients made. If a patient did not email every two weeks, the nurse sent a 
reminder. The intervention was carried out by eight psychiatric nurses. They were trained 
in coaching patients with the minimal intervention in four training sessions of 4 h, in which 
they practised writing replies to emails. After the training, the nurses were given a test to 
evaluate their skills. This test, passed by all nurses, consisted of writing replies to emails 
of fictitious patients. The nurses received 2-weekly supervision by a cognitive behavioural 
therapist experienced in CBT for CFS.
The minimal intervention is adapted for two levels of physical activity: a relative-active and a 
low- active pattern of activity [19]. Activity patterns are usually assessed with an actometer, 
a small device worn around the ankle, and activity levels are assessed over a period of 12 
days. However, as this was an implementation study, actometers were not available because 
of the high costs involved. Instead, the Physical Activity Questionnaire (PAQ) was used to 
gain an insight into the physical patterns [20]. Using a regression analysis in a group of 120 
CFS patients, for whom both PAQ and actometer scores were available, the parameters 
were obtained for a formula that predicted the patients’ activity patterns assessed with the 
actometer using the PAQ. The optimum cut-off score for the PAQ was set at 0.75, for which 
a sensitivity of 74.0% and a specificity of 79.2% were reached. If patients did not agree with 
their assignment to one of the two conditions, they were free to switch.
Outcome measures
The questionnaires were given at baseline and post-treatment or after the waiting list 
(six months after baseline assessment). The primary end-points were fatigue severity and 
disabilities. Psychological distress was a secondary end-point.
 
Fatigue. Fatigue was measured with the Fatigue Severity subscale of the CIS. This subscale 
assesses fatigue severity over the past two-week period. The questionnaire consists of eight 
items that have to be answered on a seven-point scale, with scores ranging from 8 (no 
fatigue) to 56 (severe fatigue). Reference values for healthy Dutch subjects are 17.3 ± 10.1 
[21]. The CIS has good internal consistency, and discriminative validity, and is sensitive to 
change detection [15].
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Disabilities. The level of disabilities was assessed with the SF-36 subscales ‘Physical 
Functioning’ and ‘Social Functioning’. These subscales measure the extent to which health 
interferes with a variety of activities. Scores on both subscales range from 0 (maximum 
limitations) to 100 (no limitations). Reference values for healthy Dutch subjects for physical 
and social disabilities are 83.0 ± 22.8 and 84.0 ±22.4 respectively [22]. The SF-36 is a reliable 
and valid instrument [16].
  
Psychological distress. This was assessed with the Brief Symptom Inventory (BSI) [23], 
which consists of 53 items scored on a five-point Likert scale. The BSI is a brief form of the 
Symptom Checklist 90 (SCL-90) [24]. The general severity index, which combines the number 
of symptoms and the intensity of the perceived distress brought on by the symptom, was 
used as an indicator of the current distress level.
Significant clinical improvement. To determine whether the changes in fatigue severity 
were clinical meaningful, a cut-off score for significant clinical improvement was used. 
Patients were regarded as significantly clinically improved with respect to fatigue if (1) the 
change in fatigue was statistically reliable (reliable change index >1.96) [25] and (2) the 
fatigue score at post-treatment was <35 on the CIS subscale Fatigue Severity. This latter 
score is within 2 standard deviations (SD) of the mean for healthy adults and below 2 SD of 
the mean for CFS patients [7].
Analysis
Power calculation showed that, to reach a clinical relevant change of 5.5 points on the 
subscale Fatigue Severity of the CIS, assuming a significance of 5%, a power of 85% and a 
drop-out rate of 20%, 60 patients were needed in each condition. Calculations were based 
on the results of the study testing the efficacy of guided self-instruction for CFS in a tertiary 
treatment facility [12].
 
Data analyses were performed using SPSS version 16.0 (SPSS Inc., USA) Independent-samples 
t tests and χ2 tests were used to determine whether there were differences in the patient 
characteristics at baseline between the two conditions. Analyses of the treatment effect were 
performed using mixed models. Both baseline and second assessment measurements were 
used as dependent variable, and occasion (pre/post), condition (guided self-instruction/
waiting list) and an interaction variable of both were the independent variables. Because of 
randomisation we did not expect any differences at baseline between the two conditions. 
This made it possible to use the occasion by condition interaction to test the effect of the 
treatment. Two modelling alternatives were used. The more complex model allowed for a 
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correlation between measurements of the same subjects on the two occasions, together 
with different variances at baseline and after guided self-instruction or the waiting period. 
The simpler model assumes a heterogeneous compound symmetry structure for occasion, 
thus effectively assuming the post-treatment variances in both conditions to be equal.
  
Comparisons were performed on all observed data. Significance was assumed at p <0.017 
in mixed model analyses (0.05 divided by 3, i.e. the number of primary outcome variables).
Differences between the two conditions in the proportion of patients with a significant 
clinical improvement were examined with χ2 tests on the completers. Controlled effect sizes 
for fatigue severity, physical and social functioning were also calculated ((mean difference 
intervention - mean difference control group)/SD pooled) [26] for the completers and 
compared to the previous study [12]. A sensitivity analysis was undertaken to test the 
robustness of the results of the mixed model analysis. Missing values at post-treatment 
results were replaced by last observation carried forward (LOCF) method.
The inclusion criterion that a patient must have disabilities at the level of physical and/or 
social functioning meant that not all patients experienced disabilities in physical and social 
functioning. This meant that some patients could not show the expected increase in physical 
or social functioning following the minimal intervention as they had already scored within 
the non-disabled range (>70), leading to a reduction in statistical power for these outcome 
measures. Therefore post-hoc analyses were performed for the subgroups of patients who 
did experience disabilities in physical or social functioning. Analysis of the treatment effect 
using mixed models was repeated for the subgroup of patients who scored ≤70 on the 
subscale Physical Functioning, and the subgroup who scored ≤70 on the subscale Social 
Functioning. Significance was assumed at p <0.05 for all post-hoc analyses.
 
Results
Study population
Figure 1 shows the trial profile. Of the 181 patients referred between February 2008 and 
January 2010, 142 (78%) were eligible to enter the trial. Reasons for exclusion were failure to 
meet the inclusion criteria for CFS with regard to fatigue severity, disabilities and additional 
symptoms (22%), presence of psychiatric or somatic illness (4%), body mass index (BMI) >40 
kg/m2 (2%), and aged <18 or >65 years (3%). Nineteen patients (13%, 19/142) refused to 
take part in the study because they preferred face-to-face contact, experienced remission 
of complaints, had no faith in treatment or preferred another treatment. For three patients 
the reason for refusal was unknown.
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Figure 1. Flow of participants through the study
 Did not meet the criteria for participation (n = 39)
Did not meet the CDC criteria with regard to fatigue severity, 
disabilities or additional symptoms (n = 22)
Psychiatric or somatic illness that could explain the fatigue (n= 8)
Body mass index was above 40 (n = 4)
Age was lower than 18 or above 65 (n = 5)
Referred for treatment (n = 181)
Eligible to enter trial (n = 142)  Refused participation (n = 19)
Preferred face-to-face contact (n = 4)
According to patient remission of complaints (n = 5)
Did not believe treatment would help them (n = 4)
Preferred another treatment (n = 3)
Reason unknown (n = 3)
Randomised (n = 123)
Guided self-instruction (n = 62)
Completed baseline assessment (n = 62)
Waiting list condition (n = 61)
Completed baseline assessment (n = 61)
Completed post-treatment assessment 
(n = 55)
Reason discontinued intervention:
Did not want to complete second assessment (n = 7)
Completed post-treatment assessment 
(n = 56)
Reason discontinued intervention:
Did not want to complete second assessment (n = 5)
Analysed 
(baseline n = 62, post-treatment n = 55)
Analysed
 
(baseline n = 61, post-treatment n = 56)
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The remaining 123 patients were randomly assigned to guided self-instruction (n = 62) or 
the waiting list (n = 61). In the intervention condition, 55 (89%) patients had a complete 
assessment, including three patients who filled out the shortened post-treatment 
assessment. Fifty-six (92%) patients, including four patients who completed the abridged 
questionnaire, had complete data after the waiting period. Baseline characteristics showed 
no significant imbalances after randomisation (Table 1). During the study, for 12 patients the 
diagnosis CFS turned out to be incorrect: four patients had a possible somatic explanation 
for their fatigue (e.g. brain damage), and eight patients seemed to have a psychiatric co-
morbidity, of whom two had a substance-related disorder. The 12 patients were equally 
distributed between the two conditions. None of these patients were excluded from 
analyses. 
As the results (conclusions and confidence intervals) from the simpler model were identical 
to the results from the more complex model, the results from the simpler model are 
presented for all analyses. 
Table 1. Baseline characteristics and comparison of guided self-instruction versus waiting 
list
Baseline characteristics
Guided self-
instruction
(n = 62)
Waiting list
(n = 61)
t-value(121) P
Demography
Age (years), mean (SD)
Duration of the complaints 
(months), median (min - max)
Gender (male/female)
36.3 
48 
16
(12.1)
(6 - 464)
/46
36.4
60 
11
(13.6)
(6 - 625)
/50
-0.38
-0.39
χ2 = 1.09
0.97
0.69
0.38
Outcome measures, mean (SD)
Fatigue severity
Physical functioning
Social functioning
51.0
50.0
37.7
(5.3)
(22.0)
(22.3)
51.6
51.6
41.0
(5.5)
(22.6)
(21.7)
-0.55
-0.39
-0.83
0.58
0.70
0.41
Perpetuating factors
Activity pattern (low-active/ 
relative-active)
24 /38 23 /38 χ2 = 0.13 1.00
SD, Standard deviation.
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Efficacy of the minimal intervention
The second assessment was planned six months after baseline assessment. However, not all 
patients returned the questionnaires immediately, resulting in variation in the time passed 
between the two assessments. There was no significant difference in the mean time passed 
from baseline to second assessment between the intervention condition (8.2 months, SD 
= 3.6) and the waiting list condition (7.4 months, SD = 3.5) (t = 1.23, df = 109, p = 0.16). In 
the intervention condition there was no significant correlation in the time passed between 
the two assessments and change in fatigue severity (r = 0.01, p = 0.48). During guided self-
instruction the nurses sent a mean of 12.3 (SD = 5.4) emails per patient. Patients sent a 
mean number of 8.8 (SD = 5.4) emails. There was no significant correlation between the 
numbers emails sent by the patient and change in fatigue severity (r = - 0.12, p = 0.39).
Primary analyses were based on all observed data. Patients in the intervention condition 
reported a significantly greater decrease in fatigue severity. For the outcome measures 
physical functioning, social functioning and psychological distress, the contrast was not 
significantly different between the two conditions. Mean, standard deviation and confidence 
interval on the outcome variables are presented for completers (Table 2).
After guided self-instruction, 33% of the completers showed a significant clinical 
improvement in fatigue. This percentage was significantly larger compared to the waiting 
list condition (9%) (Table 3). 
The controlled effect size was 0.70 for fatigue severity and 0.32 and 0.29 for physical 
functioning and social functioning respectively. The controlled effect sizes of the previous 
trial were 0.67 for fatigue and 0.40 for physical functioning [12]. The subscale social 
functioning was not reported in the study of Knoop et al. [12] 
The results of the sensitivity analyses on the three primary outcome variables were not 
different from the mixed model analyses (data not shown).
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Discussion
The aim of this study was to evaluate whether guided self-instruction, a minimal intervention 
for CFS carried out by psychiatric nurses, was effective when implemented in an MHC. The 
results showed a significant reduction in fatigue after the intervention compared to the 
waiting list. Significantly more patients reported a significant clinical improvement in fatigue 
following guided self-instruction. No significant differences were found on the other two 
primary outcome variables, physical functioning and social functioning, although there 
was a trend in the favour of the intervention. The level of psychological distress was not 
significantly different between the two conditions at second assessment. Controlled effect 
sizes for fatigue severity and physical functioning were similar to those in the previous 
trial testing the effectiveness of guided self-instruction for CFS [12]. A significant reduction 
in fatigue and physical functioning was found in the subgroup of patients who reported 
substantial impairments in physical functioning at baseline. We conclude from these data 
that implementation of guided self-instruction in an MHC was partially successful. It does 
lead to a reduction in fatigue, and in the subgroup of patients with physical disabilities, 
physical functioning also improves significantly. The criterion that patients with CFS 
must report impairments in physical functioning is often applied in studies testing the 
efficacy of behavioural interventions [4, 5, 10]. The results of this study justify a broader 
implementation of guided self-instruction for those CFS patients who report impairments 
in physical functioning.
Following the intervention, one third of the patients reported significant clinical improvement 
in fatigue. This is less than the 48% reported by CFS patients after regular face-to-face CBT 
[13]. Guided self-instruction could form the first step in stepped care for CFS, followed by 
additional CBT, if desirable. It has been shown that patients can profit from CBT after the 
minimal intervention. In the same study it was found that treatment outcome for stepped 
care, guided self-instruction, if necessary followed by additional CBT, is not inferior to the 
outcome of regular CBT [13]. 
Post-hoc analyses
Table 4 shows the data from the post-hoc analyses for patients with a score of ≤70 on the 
subscale Physical Functioning at baseline (guided self-instruction n = 53, waiting list n = 
50). There was a significant difference between the minimal intervention and the waiting 
list for fatigue severity and physical functioning. There was no significant difference in 
social functioning. In the subgroup of patients with a score of ≤70 on the subscale Social 
Functioning (guided self-instruction n = 58, waiting list n = 55) a significant difference was 
found in fatigue severity between the two conditions (F ratio = 13.728, df = 109.705, p 
<0.01). There were no significant differences in physical and social functioning (respectively, 
F ratio = 2.505, df = 104.726, p >0.05 and F ratio = 1.248, df = 101.223, p >0.05).
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Besides impairments in physical functioning, patients with CFS also report impairments 
in other domains of functioning. In the previous RCT testing the efficacy of guided self-
instruction [12], the Sickness Impact Profile (SIP) [27] was used to assess disabilities in all 
domains of functioning. The disabilities were found to decrease significantly following the 
intervention. However, because of the duration of the SIP and its complex scoring method, 
it was less suitable for this implementation study. We therefore decided to use the subscale 
Social Functioning of the SF-36 [16], a questionnaire that is easy to administer and score, 
and comprises only two questions. It is conceivable that the SF-36 Social Functioning has 
limited sensitivity to detect change. To our knowledge, the sensitivity of this subscale to 
change has never been demonstrated in CFS patients. A recent study showed that the Work 
and Social Adjustment Scale is a reliable and valid assessment tool for measuring disabilities 
in work and social functioning in patients with CFS [28]. The instrument is also short but 
sensitive to detecting change brought about by CBT, which makes it suitable for use outside 
specialised treatment centres. Further research is needed to determine whether not finding 
significant treatments effects on domains of functioning other than physical functioning 
is caused by the limited sensitivity of the instrument used or by a reduced efficacy when 
implementing the intervention outside a specialised treatment setting. 
Implementation of behavioural interventions for patients with CFS outside specialised 
treatment settings is not always successful. Scheeres et al. showed that CBT for CFS can 
be effective in a community-based MHC. Effect sizes for fatigue severity and physical 
functioning were similar to those of previous RCTs testing the effectiveness of CBT for CFS 
[10]. However, a recent implementation study found that the effectiveness of CBT for CFS 
differed significantly between MHCs (Wiborg et al. unpublished data). A study implementing 
pragmatic rehabilitation for CFS in primary care showed that fatigue decreased, but no 
significant effects were found for physical functioning [29]. A previous hospital-based 
trial had shown that the same treatment lead to a reduction in both fatigue and physical 
disabilities [30]. More research is needed to determine how implementation of behavioural 
interventions outside specialised treatment settings can be optimised.
By offering guided self-instruction in an MHC, instead of in a tertiary treatment centre, it 
might be assumed that patients would be referred in an earlier stage of their condition. 
The duration of illness of the CFS patients included in this trial was indeed shorter than that 
found in the previous study (median duration of complaints was 72 months versus 48 months 
in the present study) [12]. This suggests that implementation of the minimal intervention 
results in earlier treatment for CFS patients. However, the median symptom duration is still 
48 months, which is long considering that CFS can be diagnosed when patients are severely 
fatigued for six months. By diagnosing CFS in an earlier stage, the suffering of the patient 
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could be reduced, as could the societal and medical costs of the illness. With regard to age, 
fatigue severity and level of disabilities the patients who participated in the present study 
did not differ from the patients in the previous trial [12].
This study has some limitations. First, patients could only participate if they fulfilled the 
operational criteria for CFS. This was assessed on the basis of the referral letter of the GP or 
consultant, the questionnaires at baseline, and the intake session with the psychiatric nurse. 
It has been shown that diagnosing CFS on the basis of clinical assessment by a non-CFS 
specialist can lead to misclassification [31]. In our trial we tried to limit misclassifications, 
(1) by instructing the referring GPs and consultants with brochures, information letters and 
small group sessions on how to diagnose CFS according to the CDC criteria, (2) by using 
relevant questionnaires to check if a patient fulfilled the CDC criteria for CFS and (3) by 
an intake session with the psychiatric nurse, who asked patients if somatic or psychiatric 
conditions were present. However, during the trial we had to conclude that 12 patients had 
psychiatric or medical co-morbidities that could explain the presence of fatigue according 
to the CDC criteria [1, 2]. This became clear during supervision or at the second assessment 
of patients from the waiting list. In all cases the misclassifications was ascertained by the 
psychiatric nurse, who had an final interview with the patient at the second assessment, 
or by a psychologist, who performed an additional assessment. A standardised medical 
and psychiatric assessment probably would have reduced the number of misclassifications. 
However, such an assessment is difficult to conduct as part of clinical routine. Because this 
was an implementation study, we deliberately chose a less stringent procedure. Patients 
who were wrongfully included in this study were not excluded from data analyses, as the 
effects of the misclassifications on outcome were considered to be a consequence of the 
chosen implementation strategy.
Second, assessment of the physical activity patterns of patients was not based on actometer 
scores, a valid an reliable method to determine the activity pattern [19]. In the current 
study a relatively new questionnaire was used to assess the physical activity patterns. When 
using an actometer, the proportion of relatively active patients is about 75%. In the current 
study, about 60% of the patients had a relatively active physical activity pattern. Inaccurate 
allocation to one of the two treatment protocols could have influenced the treatment 
results.
Third, treatment adherence or treatment dose was not assessed. Patients were asked to 
email once every two weeks about the progress made. The researcher received a copy of 
all emails sent by the nurses and patients. The number of emails sent by the patient does 
not give specific information about treatment adherence. Patients were free to decide what 
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they emailed to the therapist, making it difficult to determine adherence form the content 
of the email. As the emails were discussed in the two-weekly supervision, it was possible 
to check if the answers of the psychiatric nurse were in accordance with the treatment 
protocol. In the previous study testing the efficacy of guided self-instruction, there was 
no relation between the number of emails sent by the patient and fatigue severity at the 
second assessment [32]. Guided self-instruction is a self-paced treatment, which makes it 
difficult to assess treatment adherence and the dose of treatment received. This is inherent 
to this type of self-management intervention, where the therapist does not set the pace of 
the intervention.
Fourth, there are no follow-up data available. As a result, we do not know if the effects of 
the intervention sustained once treatment had ended.
This study demonstrated that, after training, less-qualified mental health-care workers, 
without any prior experience in treating CFS patients were able to coach patients during 
guided self-instruction. There was considerable variability in treatment results between the 
nurses. The range in clinically significant improvement in fatigue was 17-44% (the nurse who 
treated only one patient, was not taken into account). Because of the limited number of 
participating nurses and the relatively small number of treated patients per therapist (range 
5 - 11), it was not possible to test for differences in success rates between therapists. This is 
a shortcoming of the study.
 
Finally, for implementation of guided self-instruction in an MHC, it is also important to have 
information about costs and benefits of the treatment for individual patients, the health-
care system and society. We did not perform such an analysis. An uncontrolled study [33] 
established that implementing CBT for CFS in an MHC has a favourable cost outcome ratio 
from a societal perspective. From a health-care perspective, the outcome of the ratio 
depended on the value assigned to a clinically significant improvement of CFS. 
 
To conclude, the results of this study suggest that guided self-instruction for CFS, delivered 
by psychiatric nurses, can be implemented successfully in an MHC for CFS patients with 
substantial physical disabilities. This increases the prospects of implementation of evidence-
based treatments for CFS. Wider implementation of the minimal intervention, preferably in 
the context of stepped care, would be a logical next step.
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Abstract
The efficiency and efficacy of guided self-instruction for chronic fatigue syndrome (CFS) can 
be enhanced if it is known which patients will benefit from the intervention. This study 
aimed to identify moderators of treatment response.
This study is a secondary analysis of two randomised controlled trials evaluating the efficacy 
of guided self-instruction for CFS. A sample of 261 patients fulfilling US Center for Disease 
Control and Prevention criteria for CFS was randomly allocated to guided self-instruction or 
a wait list. The following potential treatment moderators were selected from the literature: 
age, fatigue severity, level of physical functioning, pain, level of depressive symptoms, self-
efficacy with respect to fatigue, somatic attributions, avoidance of activity, and focus on 
bodily symptoms. Logistic and linear regression analyses were used with interaction term 
between treatment response and the potential moderator.
Age, level of depression, and avoidance of activity moderated the response to guided self-
instruction. Patients who were young, had low levels of depressive symptoms, and who had 
a low tendency to avoid activity benefited more from the intervention than older patients 
and patients with high levels of depressive symptoms and a strong tendency to avoid activity.
Guided self-instruction is exclusively aimed at cognitions and behaviours that perpetuate 
fatigue. Patients with severe depressive symptom may need more specific interventions 
aimed at the reduction of depressive symptoms to profit from the intervention. Therefore 
we suggest that patients with substantial depressive symptoms be directly referred to 
regular cognitive behaviour therapy.
 
65Moderators of the treatment response to guided self-instruction for CFS
5
Introduction
Chronic fatigue syndrome (CFS) is characterised by medically unexplained, prolonged and 
disabling fatigue. According to the widely used consensus criteria of the US Center for 
Disease Control, there have to be at least four of the following eight additional symptoms 
present for the CFS diagnoses to be warranted: sleep that does not alleviate fatigue, post-
exertion malaise, headaches, muscle pain, multi-joint pain, sore throat, tender lymph nodes, 
and impaired concentration or memory [1]. Cognitive behaviour therapy (CBT) is directed 
at changing cognitions and behaviours that perpetuate fatigue [2] and has been shown to 
be effective in reducing fatigue and disabilities in patients with CFS [3, 4]. However, CBT 
for CFS is only effective after 13 - 16 sessions [5-8]. As not all patients need such intensive 
treatment, a self-guided intervention has been developed [9], based on the protocol of 
CBT for CFS. Instead of face-to-face sessions, patients go through a self-help booklet with 
assignments, at their own pace and with email guidance from a therapist. 
Two randomised controlled trials (RCTs) evaluated the effectiveness of guided self-instruction 
for CFS compared to patients with CFS on a wait list [9, 10]. The first RCT was performed in 
a tertiary treatment centre. Cognitive behavioural therapists who had extensive experience 
in treating patients with CBT for CFS carried out the intervention [9]. In the second RCT, 
psychiatric nurses in a community-based mental health-care centre (MHC) were trained to 
deliver the guided self-instruction. Before the start of the study the psychiatric nurses were 
unacquainted with CBT and the treatment of CFS [10]. In both trials patients who followed 
the minimal intervention reported a significant reduction in fatigue [9, 10]. However, the 
minimal intervention sufficed for only a subgroup of the patients. Patients who did not 
profit from the minimal intervention were referred to additional CBT. It has been shown 
that patients can profit from additional CBT if the minimal intervention is unsuccessful [11].
Stepped care for CFS, consisting of guided self-instruction and followed by additional CBT 
if needed, offers the opportunity to make the treatment of CFS more efficient. Efficiency 
can be further enhanced if patients who are likely to profit from the minimal intervention 
can be identified. Identifying moderators is a way to understand the variability of outcomes 
in psychosocial interventions. Knowing moderators of guided self-instruction will inform 
which patients are likely to benefit from the intervention. It has already been shown that 
patients with an extremely high level of disabilities profit less from the minimal intervention 
compared to those without severe disabilities [9]. These patients may have better treatment 
outcomes with regular CBT than with the minimal intervention. 
Studies that investigated moderators and predictors of treatment outcome in face-to-
face CBT for CFS were reviewed. These studies show that focusing on bodily symptoms 
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and attributing symptoms to a physical cause are related to poor treatment outcomes 
[12, 13]. However, evidence concerning the latter is contradictory [6, 13, 14]. Additionally, 
patients with a high sense of control with respect to fatigue gain greater benefit from CBT 
than those with a low sense of control [6] and patients with a low activity pattern tend 
to show less improvement following CBT compared to those with a high activity pattern 
[6]. After adapting the treatment manual of CBT for CFS, the relation between the level of 
physical activity and treatment outcome was no longer present [15]. Good CBT treatment 
outcomes are associated with a change in avoidance of activity and related beliefs [16]. 
The prognostic role of depression is still unclear. Some studies found that depression was 
negatively related to treatment outcomes, whereas others found no relation [17-19]. A 
recently published study found that baseline levels of depressive symptoms, measured with 
the HADS, significantly moderated fatigue at one-year follow-up in an behavioural minimal 
intervention for CFS [20]. In contrast with these findings Prins et al. [18] found that patients 
with depression and psychological distress benefited from CBT as much as others. There is 
also evidence to suggest that high levels of pain are negatively correlated with treatment 
outcome [21]. In addition, treatment seems to be less successful when patients are older, 
are members of a self-help group, are involved in a legal procedure concerning disability 
related benefits, or received a disablement insurance benefit [6, 7, 17].
This study investigated whether factors that are related to treatment outcome in CBT, 
are moderators of response to guided self-instruction on fatigue. Most studies use the 
continuous post-treatment score in fatigue as a dependent variable to gain insight in 
predictors or moderators of treatment outcome instead of significant clinical improvement 
in fatigue. However, the latter is clinically more meaningful. Therefore, in post-hoc analyses 
we aimed to identify moderators of post-treatment fatigue (continuous) and significant 
clinical improvement in fatigue (dichotomous) following guided self-instruction. Analysis 
were adjusted for baseline levels of fatigue.
Method
This study is a secondary analysis of data obtained in two RCTs (NTR570 and NTR1223) that 
tested the effectiveness of guided self-instruction for CFS compared with people with CFS 
who were on a wait list. Patients doing the guided self-instruction went through a booklet 
with assignments. They did this at their own pace, and they had email contact with a 
therapist. Patients on the wait list received CBT or the minimal intervention after a delay of 
six months. Both trials showed that after guided self-instruction significantly more patients 
reported a significant clinical improvement in fatigue. Patients were regarded significantly 
clinically improved with respect to fatigue if (1) the change in fatigue was statistically 
reliable (reliable change index >1.96) [22] and (2) the fatigue score at post-treatment was 
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<35 on the Checklist Individual Strength (CIS) subscale Fatigue Severity [23]. The other main 
findings of both RCTs are published elsewhere [9, 10]. To explore moderators of treatment 
outcomes of guided self-instruction, we re-analysed data from the two RCTs. After baseline 
assessment, patients were randomly assigned to either the minimal intervention or a wait 
list. Assessment took place prior and subsequent to treatment or placement on a wait list.
Samples
Participants were 261 patients meeting Center for Disease Control (CDC) criteria for CFS 
[1]. The ethic committee of the Radboud University Nijmegen Medical Centre approved of 
both studies, and written informed consent was obtained from all patients. The first RCT 
tested the efficacy of guided self-instruction in a tertiary treatment centre [9]. Patients were 
18 years or older and able to speak and read Dutch. A medical and psychiatric evaluation 
was performed to exclude other causes of fatigue. All patients were severely fatigued (CIS, 
subscale Fatigue Severity ≥35), and severely disabled (Sickness Impact Profile (SIP), total 
score ≥ 700) [23, 24]. In total 169 patients were randomly assigned to either guided self-
instruction or a wait list. During guided self-instruction, qualified cognitive behavioural 
therapists gave patients feedback on their assignments. In total ten patients (guided self-
instruction n = 6, wait list n = 4) did not complete second assessment. Complete data were 
available for 78 patients following the intervention, and for 81 patients after the wait period.
 
The second RCT was delivered by psychiatric nurses in a community-based MHC [10]. All 
patients, aged between 18 and 65, were severely fatigued (CIS, subscale Fatigue Severity 
≥ 35) for at least six months and reported physical and/or social disabilities in daily 
functioning (Medical Outcomes Survey Short Form-36 (SF-36), subscale Physical and/or 
Social Functioning ≤ 70) [23, 25]. Initially, 123 patients were randomly assigned, to either 
guided self-instruction (n = 62) or a wait list (n = 61). Seven patients following guided self-
instruction and five patients of the waiting list did want to complete second assessment. 
Twelve patients (six patients of the intervention condition and six patients of the wait list) 
were excluded from analysis because of medical or psychiatric co-morbidity that could 
explain the fatigue. Misclassifications were confirmed by the nurse in attendance. Seven of 
the patients receiving a wrong diagnosis, did not also complete the second assessment. As a 
result, 52 patients included in the intervention had a complete assessment, and 50 patients 
after the wait period.
Design
Based on the existing literature of moderators and predictors of treatment outcome of 
CBT for CFS, the following variables were selected; age, fatigue severity, level of physical 
functioning, impact of pain, level of depressive symptoms, self-efficacy with respect 
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to fatigue, somatic attributions, avoidance of activity, and focus on bodily symptoms. 
Information on participants being members of a self-help group, if they were involved in a 
legal procedure concerning disability related benefits, or if they had received disablement 
insurance was unavailable.
Assessments
Sociodemographic characteristics
Gender, age, level of education, and civil status of participants were noted. 
CFS symptoms
Fatigue. The subscale Fatigue Severity of the CIS was used to measure the experienced 
fatigue over the past two-week period prior to testing [23]. This subscale consists of eight 
items, each scored on a seven-point Likert scale. High scores indicate a high level of fatigue. A 
commonly used cut-off score for fatigue severity is 35 (or higher). This score is two standard 
deviations above the mean of healthy controls. The CIS is a reliable and valid instrument for 
assessing fatigue in CFS [23, 26]. 
Pain. Pain was measured with the Bodily Pain subscale of the SF-36 [25]. This subscale 
consists of two items to measure the impact of pain and pain interference (i.e. how much 
pain limits the patient’s daily functioning). The SF-36 Bodily Pain subscale provides a score 
range between 0 (worst) to 100 (best) with respect to pain. 
Physical functioning. Disabilities were measured with the subscale Physical Functioning of 
the SF-36 [25]. On this subscale patients have to indicate if their health status limits them in 
specific activities such as walking, climbing stairs and carrying groceries. Scores range from 
0 (maximum limitations) to 100 (no limitations). The SF-36 is a reliable and valid instrument 
[8, 25].
Depression
The Brief Depression Inventory for Primary Care (BDI-PC), a short screening questionnaire 
consisting of seven items of the BDI-II, was used to assess depressive symptoms [27]. The 
BDI-PC measures depression independent of physical symptoms such as fatigue. Each 
item can be rated on a 4-point scale (0-3). If the continuous BDI-PC score is a significant 
moderator, outcomes will be dichotomised in (1) clinical relevant depressive symptoms 
(BDI-PC ≥ 4) or (2) no clinical relevant depressive symptoms (BDI-PC ≤3) [28]. This will be 
done because the dichotomous measure can be interpreted as clinically depressed versus 
non-depressed. The BDI-PC has a high internal consistency (Chronbach α = .86) and displays 
convergent validity [27].
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Perpetuating factors
Self-efficacy with respect to fatigue. To measure the patients’ sense of control over their 
symptoms, the Self-Efficacy Scale (SES-28) was used [2]. This scale consists of seven items, 
which is scored on a four-point Likert scale. The score ranges from 7 to 28 with a high score 
indicating a high sense of control. The internal-consistency of the SES-28 is good [2].
Somatic attributions. Somatic attributions with respect to CFS were measured by the causal 
attribution list. The list consists of five possible physical causes of fatigue that have to be 
scored on a four-point Likert-scale. Two examples of the questions are: ‘Do you think your 
complaints started because there is physically something wrong with you?’ and ‘Do you 
think your complaints have to do with your immune system?’. The total score ranges from 5 
to 20, with a high score indicating a strong somatic attribution. Cronbach’s alpha reliability 
is 0.74 [6].
Avoidance of activity. Five expressions of avoidance of activity were selected. The patient 
was asked if she or he (1) avoids symptoms by avoiding strenuous activity, (2) stops with 
activities in case of pain or when feeling fatigued, (3) restricts him or herself to simple 
activities, (4) takes a rest by sitting or lying down in case of pain or when feeling fatigued 
and (5) tries to take as much rest as possible to avoid symptoms. All items were scored on 
a four-point Likert scale. A high sum was indicative of a high tendency to avoid activity [23, 
29]. The Cronbach’s alpha reliability coefficient in this study is 0.80.
Focus on bodily symptoms. The Illness Management Questionnaire Factor III subscale was 
used to measure symptom focus [30]. This questionnaire is specifically designed for CFS 
patients and has been shown to have good psychometric properties. It consists of nine 
items that measure the patient’s approach to CFS in the last six months on a six-point 
Likert scale (ranging from ‘never’ to ‘always’). The patient is asked about the preoccupation 
with symptoms and whether his life is dominated by CFS. Examples of the items are: ‘I am 
constantly aware of how I am feeling’ and ‘I spend a lot of time thinking about my illness’. 
Unfortunately, data regarding the focus on bodily symptoms were not measured in the RCT 
performed in the tertiary treatment centre. 
Analysis
Data analyses were performed using SPSS 16.0 (SPSS Inc., USA). Significance was assumed at 
p <0.05 in all analyses. Both RCTs were not powered for moderator analysis but as intervention 
studies. Therefore, the moderator analyses have to be interpreted as exploratory post-hoc 
analyses. Analyses were adjusted for baseline levels of fatigue.
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Independent sample t-tests were used to determine whether there were differences in 
potential moderator variables at baseline between the two conditions (intervention versus 
placement on a wait list condition). First, treatment effect was defined as the continuous 
post-treatment score in fatigue measured with the subscale Fatigue Severity of the CIS. To 
identify whether the selected variables moderated the effect of the intervention on fatigue 
at post-treatment assessment, linear regression analyses were used to test for significant 
interactions. Each potential moderator was centred so that the mean was set at zero. By 
centring variables, multicollinearity is reduced. In linear regression models we entered, 
the continuous post-treatment score as dependent variable, the intervention dummy 
(intervention condition = 1 versus control condition = 0), the centred potential moderator, 
the intervention by moderator interaction, and the centred continuous baseline fatigue 
score at baseline as independent variables. Furthermore, setting (tertiary treatment centre 
versus community-based MHC) and the interaction with intervention, moderator and 
centred continuous fatigue interaction, were entered as independent variables. 
Second, to test the clinical relevance of our results, treatment effect-defined as significant 
clinical improvement in fatigue-was used as a dichotomous variable. Patients were regarded 
significantly clinically improved with respect to fatigue if (1) the change in fatigue was 
statistically reliable (reliable change index >1.96) [22] and (2) the fatigue score at post-
treatment was <35 on the CIS subscale Fatigue Severity. This latter score is within 2 standard 
deviations (S.D.) of the mean for healthy adults and below 2 S.D. of the mean for CFS 
patients [31]. Logistic regression analyses were performed for each potential moderator. 
The significant clinical change (significant clinical improved = 0 versus not significant clinical 
improved = 1) was entered as dependent variable. The independent variables were similar 
as used when performing linear regression analyses.
Results
Baseline characteristics
Both groups (intervention versus wait list) were similar at baseline in terms of the potential 
moderator variables. There were no significant imbalances (Table 1).
Moderator analyses
Linear regression analyses showed three significant moderators by treatment effect, namely 
age (b = 0.15, p <0.05), level of depressive symptoms (b = 0.15, p = 0.04) and avoidance of 
activity (b = 0.17, p = 0.04) (Table 2). Young patients, patients with low levels of depression, 
and low tendency to avoid activity benefited more from the intervention than older 
patients and patients with high levels of depression and strong tendency to avoid activity. 
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If outcomes of depression are dichotomised, depression still moderated the response to 
guided self-instruction (b = 0.21, p = 0.02, 95% confidence interval (CI) 1.01, 11.45). This 
indicates that patients with clinically relevant depressive symptoms (score of 4 or above 
on the BDI-PC) have a small chance of a reduction in fatigue compared to non-depressed 
patients. No significant interactions were found for the other potential moderators; fatigue 
severity, level of physical functioning, impact of pain, self-efficacy with respect to fatigue, 
somatic attributions, and focus on bodily symptoms (Table 2).
Logistic regression analyses showed only two significant moderators: level of depressive 
symptoms (b = 1.40, p = 0.01) and avoidance of activity (b = 1.34, p = 0.03) (Table 3). 
Furthermore, there was a significant interaction between the dichotomised depression 
score and the minimal intervention (b = 5.00, p = 0.04, 95% CI 1.05, 23.80). Eighteen percent 
(9/51) of the patients with clinical relevant depressive symptoms, who followed guided 
self-instruction, reported significant clinical improvement in fatigue, compared to 11% 
(5/45) of the patients on the wait list. Of the patients with no clinical relevant depressive 
symptoms 40% (31/78) showed significant clinical improvement in fatigue following guided 
self-instruction compared to 6% (5/81) of the patients with no clinical relevant depressive 
patients on the wait list. Absence of clinically relevant depressive symptoms was related 
to significant clinical improvement in fatigue. In addition, patients with low avoidance of 
activity experienced more often significant clinical improvement following guided self-
instruction compared to those with high avoidance of activity (Figure 1). 
Figure 1: Chance of significant clinical improvement for the variable avoidance of activity
Avoidance of activity
Condition
Wait list
Guided self-instruction
Ch
an
ce
 o
f c
lin
ic
al
 s
ig
ni
fic
an
t 
im
pr
ov
em
en
t
72 Chapter 5
Table 2. Interaction tests for the potential moderators from linear regression models
b 95% CI p
Sociodemographic characteristic
Age (years) 0.15  0.01, 0.45 <0.05
CFS symptoms
Fatigue
Physical functioning
Pain
-0.03
 0.11
 0.00
-0.56, 0.39
-0.04, 0.21
-0.10, 0.10
0.72
0.17
0.99
Depression  
  0.15 0.04, 1.95 0.04
Perpetuating factors
Self-efficacy
Somatic attribution
Avoidance of activity
Focus on bodily symptoms*
-0.06
 0.10
 0.17
-0.02
-1.18, 0.56
-0.32, 1.43
 0.03, 1.78
-0.61, 0.52
0.48
0.21
0.04
0.88
CI, confidence interval *For the outcome measure focus on bodily symptoms only data of the RCT 
performed in a community-based mental healthcare centre were available, as a result setting and 
the accompanying interactions were not entered as independent variables in the linear regression 
analyses.
Table 1. Baseline comparison for potential moderator variables
Guided self-instruction
(n = 130)
Wait list
(n = 131)
Sociodemographic characteristic, mean (SD)
Age (years) 37.2 (10.9) 37.9 (12.1)
CFS symptoms, mean (SD)
Fatigue
Physical functioning
Pain
49.8
51.7
53.0
(5.3)
(20.9)
(24.5)
50.3
53.6
53.9
(5.7)
(21.9)
(25.5)
Depression, mean (SD)
3.4 (2.6) 3.4 (2.9)
Perpetuating factors, mean (SD)
Self-efficacy
Somatic attribution*
Avoidance of activity
Focus on bodily symptoms**
17.3
10.7
11.9
35.4
(3.2)
(3.0)
(3.2)
(9.3)
17.2 
10.8
11.9
36.1
(2.9)
(3.1)
(2.8)
(7.1)
*For the outcome measures somatic attribution only 129 patients in the wait list condition had 
complete data. **For the outcome measure focus on bodily symptoms only data of the RCT per-
formed in a community-based mental healthcare centre were available (guided self-instruction 
n = 52, wait list n = 50)
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Discussion
In this study we examined moderators of treatment outcome of guided self-instruction. 
Three moderators of treatment outcome were found. All moderators were independently 
related to treatment outcome. Age was found to be a significant moderator of treatment 
outcome when using linear regression analyses. Patients who were older benefited less 
from the intervention than young patients. The range of age was from 18 to 68 years. It was 
not possible to determine above what age immediate regular CBT is indicated. As logistic 
regression did not show age as a moderator, higher age may not be a good reason to exclude 
patients from guided self-instruction. 
The presence of clinically relevant depressive symptoms was also found to moderate the 
response to guided self-instruction. Patients with severe depressive symptoms benefitted 
less from the intervention with respect to fatigue than those without severe depressive 
symptoms. Bentall et al. found the same in a minimal intervention: depressive symptoms 
predicted negative treatment outcomes [17]. Recently in the same type of intervention, 
Wearden et al. [20] also found that higher levels of depressive symptoms were associated 
Table 3. Interaction tests for the potential moderators from logistic regression models
b 95% CI p
Sociodemographic characteristic
Age (years) 1.06  0.99, 1.13 0.10
CFS symptoms
Fatigue
Physical functioning
Pain
0.95
1.04
1.01
0.84, 1.08
1.00, 1.08
0.98, 1.04
0.43
0.06
0.77
Depression 
  1.40 1.08, 1.82 0.01
Perpetuating factors
Self-efficacy
Somatic attribution
Avoidance of activity
Focus on bodily symptoms*
0.81
 1.13
 1.34
 1.02
0.62, 1.05
 0.87, 1.46
 1.03, 1.74
 0.87, 1.20
0.11
0.36
0.03
0.80
CI, confidence interval *For the outcome measure focus on bodily symptoms only data of the RCT 
performed in a community-based mental healthcare centre were available, as a result setting and 
the accompanying interactions were not entered as independent variables in the linear regression 
analyses.
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In a previous trial performed in a tertiary treatment centre, disabilities in different domains 
of functioning were associated with an unfavourable treatment response [9]. In this trial we 
chose to focus on disabilities in physical functioning, measured with the SF-36. The subscale 
Physical Functioning of the SF-36 measures disabilities in rather simple activities like carrying 
groceries, climbing stairs and walking [25]. The SIP measures disabilities in more complex 
activities such as work, social interactions, recreation and pastimes [24]. Physical functioning 
did not moderate treatment outcome. This is in contrast when disabilities are measured 
with the SIP. This finding implies that the SIP and the SF-36 not only measure different 
domains of functioning, but also that both questionnaires have a different relationship with 
the response to treatment, suggesting that it is important to operationalise the concept 
disabilities in different ways in CFS research.
Our study has several limitations. Both RCT’s were designed to evaluate the effectiveness 
of guided self-instruction for CFS [9, 10]. As a result, data on some potential moderators of 
treatment outcome, as previously found in other studies, were not assessed. In addition, 
data regarding the focus on bodily symptoms were only available for the RCT performed in 
the mental health-care setting, which decreases the statistical power to identify moderators. 
Furthermore, we did not adjust the p-values for multiple testing. As this was an explorative 
study we chose not to correct for multiple testing. Replication of our study is necessary to 
confirm our results.
In conclusion, patients who show signs of avoidance of activity and patients with substantial 
depressive symptoms (BDI-PC ≥4) benefit less from guided self-instruction than patients with 
low tendency to avoid activity and those without severe depressive symptoms. Avoidance of 
activity has been suggested to be an important factor in the maintenance of CFS symptoms. 
Our results suggest that in a model of stepped care for CFS, patients with clinically relevant 
depressive symptoms may have better treatment outcomes if they are directly referred to 
CBT, as depressive symptoms do not seem to be a treatment moderator for regular CBT 
[18, 19]. Assessing patients’ suitability for guided self-instruction is necessary for further 
development of a model of stepped care for CFS. By identifying moderators of treatment 
outcomes, variability of treatment outcome can be reduced, and treatment efficacy and 
efficiency enhanced. 
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Abstract
The aim of our study was to explore whether community-based mental health care centres 
(MHCs) are able to implement and sustain cognitive behaviour therapy (CBT) for chronic 
fatigue syndrome (CFS) with the help of an implementation manual. We monitored the 
implementation process and treatment outcome data of three Dutch MHCs that implemented 
or sustained CBT for CFS, one in the context of a stepped care programme. We compared 
these data with findings of other treatment studies conducted in the context of CBT for 
CFS. All three MHCs included at least 40 patients with dropout rates between 15% and 35% 
from intention-to-treat to second assessment. Effect sizes ranged between 0.88 and 1.76 for 
changes in fatigue severity and 0.43 and 1.23 for changes in physical functioning. With one 
exception, these outcomes were within the range of our benchmark. Contrary to original 
expectations, we provided additional implementation support to the two MHCs new with 
CBT for CFS. We concluded that our implementation manual does not seem to substitute 
external support for team leaders and associated professions during initial implementation 
of CBT for CFS but may have the potential to make this assistance more efficient. Particular 
attention should be paid to challenges of implementing stepped care for CFS.
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Introduction
Patients with chronic fatigue syndrome (CFS) suffer from medically unexplained and severely 
disabling fatigue that lasts for at least six months [1]. During the last two decades, cognitive 
behavioural therapy (CBT) for CFS has been developed and tested in specialised treatment 
settings [2-6]. In CBT for CFS, dysfunctional illness beliefs are usually challenged through a 
gradual increase in activity and cognitive restructuring techniques. This strategy is effective 
in reducing fatigue and disabilities in CFS patients [7-9].
Consequently, there is a growing interest in the dissemination of CBT for CFS outside 
specialised settings. For example, the Health Council of the Netherlands [10] urged to 
implement CBT for CFS on a large national scale to treat an estimated number of 30 000−
40 000 Dutch CFS patients. It has been argued before that community-based mental health 
care centres (MHCs) are most suitable for implementation of CBT for CFS in the Netherlands 
[11]. In contrast to primary care practices or general hospitals, these settings usually employ 
cognitive behavioural therapists and have sufficient financial resources to invest in new 
specialised treatments. In addition, somatic attributions are less likely to be reinforced in 
mental health care settings.
Scheeres, Wensing, Knoop, and Bleijenberg [12] examined the specific requirements for 
successful implementation of CBT for CFS in a Dutch MHC. They found that therapists 
needed specific training and supervision in addition to the CBT for CFS manual in order to 
treat patients effectively. Also, referrers and patients had to be informed regularly about 
the new treatment options so that treatment capacities could be exploited adequately. In 
addition, an optimised patient flow, which included the avoidance of prolonged waiting 
periods, was necessary to reduce unexpectedly high dropout rates. A benchmark analysis 
showed that the effect sizes of the MHC were similar to the uncontrolled effect sizes of CBT 
for CFS in randomised controlled trials (RCTs) [12].
 
On the basis of this promising finding, Scheeres and Bleijenberg [13] wrote a manual in 
which they described their experiences with implementing CBT for CFS outside specialised 
settings. The main idea of this manual was that MHCs might be able to adopt CBT for CFS 
without additional help when they are adequately informed about the specific demands of 
the implementation. This could be of particular advantage for cost-efficient dissemination 
of evidence-based practice for CFS on a large scale. The aim of the present study was to 
examine whether three MHCs were able to implement and sustain CBT for CFS with the 
help of the implementation manual introduced by Scheeres et al. [13]. We evaluated 
implementation process and treatment outcome data of these MHCs.
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Methods
Setting
Our study was conducted at three Dutch MHCs. One was located in an urban region in the 
west of the Netherlands. The two other MHCs were located in rural areas, one in the east 
and one in the south of the Netherlands. All MHCs selected a team of cognitive behavioural 
therapists that were willing to participate in our study. The number of therapists who treated 
patients with CFS varied between seven at the Eastern, two at the Western, and four at the 
Southern MHC. Each MHC also selected a team leader to coordinate the implementation of 
CBT for CFS. 
All team leaders received the implementation manual of Scheeres et al. (13), which contained 
specific information about the use of CBT for CFS outside specialised treatment settings. 
This information included recommendations about selection, training and supervision of 
cognitive behavioural therapists, activities to inform potential referrers and patients about 
the new treatment option, and optimizing the patient flow from initial referral to the end 
of treatment, including routine assessment of fatigue and disabilities prior and subsequent 
to the treatment period. Treatment was based on the manual by Bleijenberg, Prins, and 
Bazelmans [14] and included goal setting, fixed sleep wake cycles, changing the focus on 
bodily symptoms, a systematic challenge of fatigue-related beliefs, regulation and gradual 
increase of activity, and the accomplishment of personalised goals.
The Eastern MHC sustained CBT for CFS from the study conducted by Scheeres et al. [12, 
13]. Therapists at this MHC received supervision in CBT for CFS once a month for one and 
a half hour. The Western and the Southern MHCs had no specific experience with the 
treatment of CFS patients and both newly implemented CBT for CFS. Therapists received 
a CBT for CFS manual, a 4-day training, and supervision twice a month for one and a half 
hour. The training and supervision of therapists was provided by members of our research 
team. Implementation progress was discussed with the team leaders at biannual research 
meetings.
The Southern MHC also had a team of psychiatric nurses that delivered a low-intensity 
intervention for CFS in the context of a stepped care programme. The low-intensity 
intervention consists of written self-instructions on the basis of the manual by Bleijenberg 
et al. [14] and e-mail contact with a trained therapist [4]. There is evidence that stepped 
care for CFS is equally effective but more time efficient than face-to-face CBT alone [15]. 
Effects of the low-intensity intervention at the Southern MHC were examined in the context 
of an RCT that is outside the scope of this study [16]. In the present study, we focused on 
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data that were gathered during face-to-face CBT. Patients who were not improved following 
the low-intensity intervention were referred to face-to-face CBT as subsequent intervention. 
However, patients could also directly start with face-to-face CBT without following the low-
intensity intervention (e.g., when they did not meet the inclusion criteria of the RCT).
Patients
Patients were referred by a general practitioner or consultant with the diagnosis CFS that 
implied that patients were suffering at least six months from severe and disabling fatigue 
in the absence of a medical explanation for the complaints as defined in the CDC criteria 
for CFS [1, 17]. These criteria were confirmed by a therapist of the MHCs upon intake. We 
included patients with a fatigue severity score of 35 or higher on the Checklist Individual 
Strength (CIS) and a score of 65 or less on the physical and/or social functioning scale of the 
Short Form Health Survey (SF-36) at baseline assessment. All patients were at least 18 years 
of age.
Measures
The subscale Fatigue Severity from the CIS was used to indicate the level of fatigue [18, 
19]. This scale consists of eight items that are scored on a seven-point Likert scale. The sum 
score varies between 8, no fatigue, and 56, very severe fatigue. The cut-off score for severe 
fatigue was 35 (or higher). The level of disabilities was measured with the subscales Physical 
and Social Functioning from the 36-item SF-36 [20]. The scores on both scales range from 
0, maximal limitations, to 100, maximal functioning. The cut-off score for severe disabilities 
was 65 (or less) on physical and/or social functioning. The level of fatigue and disabilities 
was assessed prior and subsequent to the treatment period.
Data collection
We monitored the implementation data in collaboration with the MHCs who provided 
routinely collected and anonymised patient information on a regular basis to us. This 
information included the number of patients per stage of the patient flow (i.e., referral, 
start of treatment end of treatment) and the assessment of fatigue and disabilities. Data 
were collected between June 2008 and February 2011. 
Evaluation
Implementation process 
Consensus was reached prior to the study that at least 40 patients should be included per 
MHC to be able to draw meaningful conclusions about the implementation of evidence-
based practice for CFS. We defined dropout as not having completed second assessment. An 
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upper limit of 37% dropout from intention-to-treat to second assessment was considered to 
be tolerable. This proportion was derived from a study by Quarmby, Rimes, Deale, Wessely, 
& Chalder [21], who reported about dropout outside randomised trials in the context of CBT 
for CFS.
Treatment outcome
We determined the number of clinically improved patients with a reliable change index 
of >1.96 on the CIS fatigue severity, a fatigue severity score of <35 and a SF-36 physical 
functioning score of >65. We followed the statistical benchmark procedure of Scheeres et al. 
[12] using an uncontrolled pre−post benchmark effect size for fatigue severity and physical 
functioning which was calculated as (Mean baseline − Mean post-treatment) / pooled SD. Effect sizes 
that were within the 95% confidence interval of the statistical benchmark were considered 
to be similar to the uncontrolled effect sizes of CBT for CFS in RCTs.
Effect sizes were computed on the basis of intention-to-treat but patients who were still 
in treatment at the end of our study were excluded from the analyses. Missing data from 
patients who decided not to start with treatment or who were no longer in treatment and 
had not completed second assessment were imputed as last observation carried forward. 
Results
Implementation process 
As described, we defined success in terms of the implementation process as 40 or more 
inclusions per MHC with a maximum dropout rate of 37% from intention-to-treat to second 
assessment. Each of the three MHCs fulfilled these criteria at the end of the implementation 
period (Table 1). Analysis of baseline characteristics revealed that dropouts had significantly 
higher levels of pre-treatment fatigue than completers (p ≤ 0.05). Mean fatigue in dropouts 
was 53.2 (SD = 3.9). Patients who completed second assessment had a mean of 50.7 (SD = 
5.2). Differences in age, gender as well as physical and social functioning were not significant.
Halfway through the implementation process, our monitoring data revealed less inclusions 
than expected at the two new MHCs. Also, all MHCs had problems with the inclusion 
to completion ratio (Table 1). These problems were most obvious at the Southern MHC 
where 1 out of 16 included patients had completed second assessment after 15 months of 
implementation. We discussed these data at one of the biannual research meetings with 
all team leaders and agreed to provide external support in addition to the implementation 
manual to optimise the use of CBT for CFS. 
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Table 1.  Implementation process data per MHC
Eastern
MHC
Western
MHC
Southern
MHC
Inclusion 
Mean age (SD)
Female
75
37.2
63
(11.6)
(84%)
40
32.3
30
(10.8)
(75%)
48
42.6
40
(10.8)
(83%)
Treatment
Started*
Completed**
Mean sessions (SD)***
67
43
11.5
(64%)
(5.3)
39
33
12.8
(85%)
(3.6)
47
32
10.3
(68%)
(4.5)
Dropout
Waiting for treatment
During treatment*
Intention-to-treat*
8/75
15/58
23/66
(11%)
(26%)
(35%)
1/40 
5/38
6/39
(3%)
(13%)
(15%)
1/48 
5/37
6/38
(2%)
(14%)
(16%)
1st half of the process**** 
Included
Completed
43
8
21
5
16
1
Percentages may not equal 100 because of rounding. *Some patients were still in treatment at 
the end of the study. **Based on completion of second assessment. ***Based on completers. 
****Based on data available at Sept. 2009.
This support was provided during the second half of the implementation period by members 
of our research team to the team leaders and administrative employees of the Western and 
Southern MHCs where CBT for CFS was newly implemented. It was delivered on the basis 
of an informal assessment of potential implementation barriers using the monitoring data 
and our communication with the team leaders of the MHCs. We did not intervene in the 
sustaining process of the Eastern MHC that did not express a need for additional support.
The additional support included monthly feedback about the monitoring data for the 
team leaders of the Western and the Southern MHCs to enhance awareness of the 
implementation progress. This feedback contained an overview of the patient flow such 
as the number of included and treated patients, the average time patients waited for 
treatment, the average treatment time and information about the use of assessments. This 
information was interpreted by us in terms of implementation success (i.e., how many more 
inclusions and completers are needed and what is the tolerable dropout rate). We provided 
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administrative employees with information about missing data. In some cases, we assisted 
in the assessment of fatigue and disabilities. We also provided administrative employees 
with information about potentially stagnating treatments (i.e., treatment periods of more 
than six months). At the Western MHC, we supported the adoption of the monitoring 
system by one of the therapists due to structural problems at the level of the administrative 
employees.
We also stimulated both team leaders to intensify their patient recruitment activities 
and to optimise the patient flow for CFS patients at their MHCs in accordance with the 
implementation manual to increase the number of inclusions and to improve inclusion to 
completion ratios. At the Western MHC, we stimulated personal presence at meetings of 
general practitioners and publications in local newspapers. At the Southern MHC, activities 
were stimulated that focused on motivating patients to continue with treatment after 
ineffective low-intensity interventions for CFS. Only 10 of the 23 patients (43%) who were 
eligible to continue their treatment in the context of stepped care halfway through the 
implementation period had actually started with face-to-face CBT. We also stimulated team 
leaders to reduce prolonged waiting and treatment periods to avoid patient attrition.
At the end of our study, the team leaders of the Western and Southern MHCs reported 
that the external support helped them to gain more insight into the progress of their 
implementation and at the same time helped everyone to keep focused and motivated 
during the implementation process. All team leaders appreciated the fact that they were 
able to determine how much additional support was provided.
Treatment outcome
Treatment outcome data per MHC are presented in Table 2. Besides the number of 
clinically significant improved patients, we calculated uncontrolled effect sizes for fatigue 
severity and physical functioning. We defined success in terms of treatment outcome as 
uncontrolled effect sizes that were inside the range of the 95% confidence intervals of the 
statistical benchmark. The Eastern and Western MHCs both had effect sizes that ranged 
within these confidence intervals. The effect sizes for face-to-face CBT at the Southern MHC 
were significantly lower than the effect sizes of the statistical benchmark. 
In total, forty-eight patients were included for face-to-face CBT at the Southern MHC. fifty 
percent of the patients (n = 24) had received a low-intensity intervention for CFS before 
face-to-face CBT in the context of stepped care. Two of these patients were still in treatment 
at the end of the study. Four patients (18%) showed clinically significant improvement. The 
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Table 2.  Treatment outcome data per MHC 
Eastern
MHC
Western
MHC
Southern
MHC
Intention-to-treat*
Clinically sign. Improved (%)
66
26 (39%)
39
26 (67%)
38
    9 (24%)
Mean Δ fatigue (SD)
Uncontrolled effect size
Statistical benchmark**
-13.9 (15.6)
1.19
0.97-1.89
-24.0 (18.7)
1.76
0.97-1.89
-8.6 (13.4)
0.88
0.97-1.89
Mean Δ phys. functioning (SD)
Uncontrolled effect size
Statistical benchmark**
14.8 (21.2)
0.65
0.63-1.44
29.9 (26.8)
1.23
0.63-1.44
10.3 (22.0)
0.43
0.63-1.44
Completers***
Clinically sign. improved (%)
Mean Δ fatigue (SD)
Mean Δ phys. functioning (SD)
43
    26 (60%)
-21.3 (14.7)
 23.0 (22.3)
33
    26 (79%)
-28.4 (16.9)
 35.3 (25.6)
32
      9 (28%)
-10.2 (14.0)
 12.2 (23.5)
*Patients who were still in treatment were excluded. **95% confidence interval derived from 
Scheeres et al. 2008. ***Patients who did not complete second assessment were excluded.
other 50% (n = 24) of the inclusions had not received a low-intensity intervention for CFS 
prior to face-to-face CBT. Eight of these patients were still in treatment at the end of the 
study. Five patients (31%) showed clinically significant improvement.
Discussion
Implementation process 
The purpose of the present study was to examine whether MHCs are able to implement and 
sustain CBT for CFS with the help of the implementation manual introduced by Scheeres 
et al. [13]. All three MHCs included at least 40 patients and none of the MHCs exceeded 
the tolerable dropout rate of 37% from intention-to-treat to second assessment. Contrary 
to original expectations, however, we provided additional support to the two new MHCs 
during the second half of the implementation process. This support included assistance for 
the team leaders in translating the implementation manual into practice and administrative 
employees in processing the monitoring data into meaningful feedback for those involved in 
the implementation process.
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We believe that the additional support helped the new MHCs to increase their insight into 
the specific challenges of implementing CBT for CFS including potential ways about how to 
cope with these challenges. Yet, due to the design of our study, which lacked a proper control 
condition, we cannot say in what way our support ultimately influenced the implementation 
process of these MHCs. It is obvious, although, that we seem to have underestimated the 
need for supervision of those professionals who were not directly involved in the treatment 
of patients [22]. Consistently, our implementation manual does not seem to substitute 
external assistance for team leaders and associated professions. However, on the basis of 
our experiences with the initial implementation of CBT for CFS in the Eastern MHC [12], 
the implementation manual does seem to have the potential to make this assistance more 
efficient that would be of advantage for large-scale implementation of evidence-based 
practice for CFS.
Although the Eastern MHC had problems during the implementation process as well, this 
MHC was capable of sustaining CBT for CFS without additional support. It is possible that 
the relatively high dropout rates of this MHC would have been lower if we had provided 
additional support. Yet, as this problem was already addressed by Scheeres et al. [12] with 
limited success, these dropout rates may concern a structural problem of the MHC that 
might have been hard to influence by the professionals involved in the implementation of 
CBT for CFS. Critical to us in the decision not to deliver external support was the fact that the 
Eastern MHC did not express a need for additional assistance. The level of implementation 
support might thus best be adapted to the specific needs of individual MHCs in future 
implementations until more data are available.
Treatment outcome
According to the statistical benchmark, effect sizes of the Eastern and the Western MHCs 
were similar to the uncontrolled effect sizes of CBT for CFS in RCTs. This result is another 
promising finding for future implementations of CBT for CFS outside specialised treatment 
settings. At the same time, the Southern MHC had significantly lower effect sizes than the 
statistical benchmark. There are several explanations that may account for this finding. One 
possibility is that therapists at the Southern MHC may have been less effective in treating 
CFS patients according to the evidence-based standard. A study in the context of manualised 
CBT for CFS showed that therapists inside specialised settings do not affect treatment 
outcome [23]. However, on the basis of our monitoring data, we found that therapists in 
community-based settings seem to differ in their efficacy that might be due to their attitude 
towards working with treatment manuals [24]. 
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Another possible explanation for the differences in effect sizes is the specific implementation 
scenario of the individual MHCs. In particular, the Southern MHC implemented more than 
one cognitive behavioural intervention at the same time in the context of a stepped care 
programme for CFS. None of the cognitive behavioural therapists were specifically trained 
for face-to-face contact with patients who already had received an ineffective low-intensity 
intervention which may have biassed treatment outcome in disadvantage of this MHC. In 
particular, uncomplicated patients who are likely to respond to treatment might have been 
filtered out at the level of the low-intensity intervention. A more complex subpopulation of 
CFS patients in face-to-face CBT at the Southern MHC might have been the result. Although 
the number of patients was too small to test these differences statistically, our clinically 
significant improvement rates indicate that face-to-face CBT for patients who had received 
the low-intensity intervention may have been less effective than face-to-face CBT for patients 
who had not received the low-intensity intervention. 
We believe that an interaction of factors at the level of the therapist and the level of the 
treatment setting is most likely to explain our findings. Unfavourable attitudes of therapists 
towards manualised therapy before the implementation had begun may have been reinforced 
by a complex patient population for which there were no specific recommendations in the 
standardised treatment manual. This may have caused these therapists to try alternative 
strategies. Leaving the evidence-based procedure, in turn, may have inhibited established 
treatment effects.
On the basis of these findings, we would discourage implementation of the low-intensity 
intervention before therapists had sufficient time to develop a routine in face-to-face CBT. 
Extra therapist training may in addition help to warrant that therapists feel sufficiently 
prepared to meet the specific challenges of patients who did not respond to the low-
intensity intervention. When these conditions are met, stepped care may be as effective in 
community mental health care, as it has been found to be in a specialised tertiary setting 
[15]. Refusals of face-to-face CBT after ineffective low-intensity interventions should be 
separately addressed in future studies, as this was a problem in the specialised setting as 
well.   
Limitations
Apart from the naturalistic study design that lacked proper control conditions, there are 
other limitations to our study. Due to the heterogeneity of community-based mental health 
care, our findings may not fit seamlessly into other settings in and outside the Netherlands. 
Although we paid attention to factors that may be relevant for future implementations in 
our selection of MHCs (e.g., rural and urban regions are represented as well as different 
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implementation scenarios), future research will have to demonstrate how well our findings 
generalise to these settings.
The generalisability of our findings may also be limited by the fact that therapists knew that 
their treatments would be monitored in the context of a scientific study. Routine outcome 
monitoring is an element of evidence-based practice for CFS. Anonymised CBT for CFS data 
could thus be gained outside the context of scientific studies in the future, e.g., by using 
health care insurance data. These data could be compared with our findings to exclude the 
possibility of a bias due to observation. 
As we do not have any follow-up data, we also do not know whether treatment effects 
are stable in patients who were treated in community mental health care. Future studies 
should test whether patients benefit persistently from evidence-based practice for CFS that 
was delivered outside specialised treatment settings. It would also be interesting to gather 
follow-up data on the treatment effects of the Southern MHC to find out whether effect 
sizes will increase and which factors may have contributed to such an increase.
Conclusions
Our findings suggest that MHCs are capable of implementing CBT for CFS with convenient 
effect sizes and tolerable dropout rates on the basis of intention-to-treat. At the same time, 
our data suggest that the implementation of stepped care for CFS is more complex than 
implementing face-to-face CBT alone and deserves additional attention and preparation. 
In particular, implementation of the low-intensity intervention may better be postponed 
until therapists have gathered sufficient experience with face-to-face CBT. Contrary to our 
expectations, our implementation manual does not seem to substitute external support but 
may help to make this support more efficient for large-scale implementation of evidence-
based practice for CFS. The implementation manual could be improved on the basis of these 
and upcoming findings.
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In this final chapter, the results of the studies of this dissertation will be discussed. A 
distinction will be made between the practical implications of findings (Part I) and how 
findings relate to the existing literature on implementation of evidence based treatments 
for Chronic Fatigue Syndrome (CFS) (Part II). As previously mentioned, in the Netherlands 
there is limited availability of cognitive behavioural therapy (CBT) for CFS. If this availability 
increases, more CFS patients can be treated with CBT, which would not only decrease 
patient suffering, but also decrease the costs of CFS to society, which are related, among 
others, to medical expenses, work absenteeism, and costly career changes. The Expert 
Centre for Chronic Fatigue has over the past years conducted studies on possibilities for 
implementation of treatment for CFS outside specialised treatment centres. The results of 
this research are described in Chapters 4 and 6 of this dissertation. A logical next step is to 
expand the implementation of treatment for CFS to other mental health centres with the 
aim to work toward national implementation of stepped care for CFS. In 2011, we described 
the steps toward this goal in an article that was published in the journal Gedragstherapie. 
This article is reprinted here as Part I of the discussion.
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Summary
Approximately 30 000 to 40 000 patients in the Netherlands suffer from chronic fatigue 
syndrome (CFS). Currently, treatment options for these patients are limited: the need for 
treatment is higher than can be delivered. In recent years, research has been done into the 
possibility of implementing cognitive behaviour therapy (CBT)—one of the few treatment 
approaches to CFS that has proven to be effective—into MHCs. This appears to be a 
possibility, providing that CFS specialists are involved in this process. Recently it has been 
shown that a minimal intervention—guided self-instruction with email support—based on 
CBT for CFS is effective in the reduction of disabilities and fatigue. These two approaches, 
guided self-instruction and individual CBT, constitute a stepped care approach for CFS. It is 
desirable to implement this model nationally, so that all CFS patients can receive effective 
treatment—regardless of their geographical location. In this article, concrete steps that are 
necessary for successful national implementation for treatment of CFS are described. 
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Introduction
When is someone affected by CFS? 
Most people experience fatigue on a daily basis. The next morning, or after rest, this fatigue 
has disappeared. If fatigue is severe, lasts longer than six months, and is accompanied by 
limitations in functioning, then this could be indicative of chronic fatigue syndrome (CFS)—
even more so if there are additional symptoms such as muscle aches, joint pain, headaches, 
and problems with concentration or memory. We only speak of CFS when there is no 
medical explanation for the fatigue. In the Netherlands, approximately 30 000 to 40 000 
patients suffer from CFS [1, 2], though a recent study suggests that these numbers may be 
far higher [3].
What are treatment options?
Cognitive behaviour therapy (CBT) is one of the few treatment approaches to CFS that 
has shown to be effective [4, 5]. CBT for CFS aims at changing cognitions and behaviours 
that sustain the fatigue. Important elements in this type of treatment are changing the 
dysfunctional fatigue related cognitions (increasing self-efficacy and reducing catastrophising 
and excessive focus on bodily symptoms), and an increase in activity levels [2]. CBT is 
effective, but appears to be a difficult treatment approach for health-care professionals and 
patients alike [6]. It is intensive, requiring 13 to 16 sessions with highly specialised cognitive 
behavioural therapists. In the past years, CBT for CFS has been implemented in three Mental 
Health Centres (MHCs), but national treatment capacity for CFS in the Netherlands is still 
insufficient. Expansion of treatment possibilities is crucial to ensure that more patients with 
CFS can receive the care they need. 
What is stepped care for CFS?
Stepped care ensures that a patient gets the kind of care he or she needs. Step one in 
a stepped care model for CFS is guided self-instruction supported by email. Guided self-
instruction is comprised of a workbook with instructions that are based on the CBT protocol 
for CFS. This treatment is carried out independently in the patient’s home, supported by 
email communications with a cognitive behavioural therapist. This minimal intervention is 
followed by individual CBT for CFS if step one was insufficiently effective or if even prior 
to guided self-instruction it was clear that the minimal intervention will not suffice. A 
randomised controlled study in a third line health care facility centre showed that guided 
self-instruction with support via email is effective [7]. The model of stepped care was also 
tested for efficacy in a CFS centre and found to be effective (Chapter 3) [8].
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Where can stepped care for CFS be implemented?
Institutions or organisations have to meet a number of criteria in order to be eligible for 
implementation of a stepped care program for CFS. Multiple psychologists have to be 
employed at the facility to enable peer review and consultation and to ensure that the 
skills learned are maintained. It is also crucial that the psychologists are licensed cognitive 
behavioural therapists (in training) with time for and interest in training and supervision. In 
addition, the organisation or facility has to be able to offer 13-16 treatment sessions. Two 
organisations meet these criteria for implementation of CBT for CFS: first line practices and 
MHCs. Hospitals were not eligible because general practitioners in the Netherlands cannot 
directly refer a patient to a psychologist in a hospital. These patients are often first referred 
to a medical specialist (neurologist or internist) who often orders additional medical 
procedures, leading to unnecessary additional costs. 
Psychologists in the first line have experience working with patients with physical symptoms, 
which makes this setting potentially suitable for implementation of stepped care. However, 
CBT for CFS is a long-term treatment for which first line practices are unlikely to be fully 
reimbursed by insurers. First line practices are also often based on sole proprietorship, 
which makes peer review and consultation impossible. 
MHCs are more suitable for implementation of stepped care for CFS. The specialised nature 
of CBT for CFS fits well with current developments in these institutions and MHCs are 
familiar with CBT as an approach to psychotherapy. Issues such as anxiety and depression 
are already successfully being treated with CBT in MHCs, and there are numerous trained 
therapists there who can be trained to treat CFS with CBT. This also ensures continuity in 
care—should one health-care professional become unavailable—the knowledge gained 
regarding treatment of CFS is not lost. For these reasons, it is our preference to implement 
stepped treatment for CFS in MHCs.
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Method of implementation
Which steps are needed for implementation?
In 2003, implementation of CBT commenced at GGnet, an MHC in the eastern part of 
the Dutch province of Gelderland. After three years, the process as well as impact of the 
treatment was examined. It appeared that it was possible to implement CBT for CFS under 
certain conditions [9]. These conditions are outlined in manual, which can be used by other 
MHCs that have an interest in the implementation of CBT for CFS [10]. The most important 
conditions are listed below. Organisation/management/therapists have to be willing to:
1. Make therapists trained in behavioural therapy available for training and supervision 
so that there is sufficient expertise to ensure that execution of treatment is in keeping 
with quality standards.
Experience has taught us that CBT for CFS is a difficult treatment, which is only effective 
when done by cognitive behavioural therapists who are trained in CBT for CFS [11]. In order 
to be eligible for training for CBT for CFS, therapists have to have completed a basic course in 
behavioural therapy that is recognised by the Dutch association for behavioural and cognitive 
therapies (VGCt). These therapists also have to be cognitive behavioural therapists in training 
with VGCt. A certification regulation is in place to ensure that (1) CFS patients are treated 
by experienced and well-educated therapists, who (2) evaluate their treatment thoroughly, 
who (3) use specific instruments for this evaluation, and who (4) undergo additional training 
and professional development (for more information, see www.umcn.nl/cv). The difficulties 
in treatment for CFS include motivating patients, preventing dropout, identifying and 
challenging relevant cognitive patterns, establishing recovery as treatment goal, solving 
problems when regulating activities, dealing with complaints and symptoms of pain, 
establishing and implementing back-to-work plans, and dealing with co-morbidity [2, 11]. 
Patients with CFS are new to MHCs, and it is important that therapists learn to understand 
and work with patients who attribute symptoms to somatic causes. Motivating patients at 
the start of therapy is an art and crucial at the same time, as creating the right conditions 
increases the chance of positive treatment outcomes. The (change in) attitude in the patient 
is an important element in this. Supervision for one to two years, depending on intensity 
of treatment and case load by a cognitive behavioural therapist who has specialised in 
CFS is necessary to ensure that the treatment is done right, plus it is also a condition for 
certification. In the training of CBT for CFS, thorough attention is given to the treatment 
protocol to enable therapists to work with it. Nonetheless, therapists will -especially in 
the first few years- encounter challenges. These need to be openly discussed so that the 
therapist can carry on in confidence and make the right decisions. 
104 Chapter 7
2. Create organisational conditions to better enable patients with CFS to enter 
treatment.
Organisations need to implement an intake program specifically for patients with CFS. These 
patients should not enter a general intake procedure but be immediately referred to a CBT 
therapist for CFS. CFS patients often attribute their symptoms to physical ailments, which 
does not match a typical intake at an MHC. A regular intake does not suit the experience of 
the symptoms, which can lead to premature dropout. A specific intake with direct attention 
to CFS is needed. Better intake of patients with CFS can be achieved through something as 
simple as an email address that referring health care professionals can use to refer patients 
with CFS.
3. Inform general practitioners, other health care professionals, and patients of 
treatment options. 
Health care professionals are important for successful implementation of treatment for CFS. 
They need to be informed of the possibility to refer patients with CFS to an MHC. A variety 
of ways to convey information can help inform health care professionals about this new 
option. Health care professionals need not only to know about referral options, they also 
need to be able to recognise and diagnose CFS and motivate patients to enter treatment, 
so aside from knowing about treatment, physicians need additional educational materials 
regarding CFS. This can be thorny as physicians are bombarded with information. Therefore, 
it is helpful to repeat the information and to use a variety of channels to convey it. Repeated 
distribution of written information to physicians has proven to be effective, with ‘repeated’ 
meaning that at least four times in the first two years an informative letter and brochure is 
sent to health care professionals [12]. Aside from written materials, small-scale information 
sessions have also shown to be effective [12]. These sessions offer physicians an excellent 
opportunity to ask questions, engage in discussions, or express reservations, for example 
about a CFS diagnosis or treatment outcomes. A good way to organise such meetings is 
trough collaboration with district based physicians collectives. Having accreditation 
applications for physicians who attend the meeting will increase turnout. 
4. Inform and familiarise other health care workers, so that patients with CFS enter the 
right treatment program. 
As is the case with any specialised treatment, only a few select people are directly involved 
in the treatment for CFS. It is however also important that those less involved know the 
what, why, and how of the new treatment to prevent patients with CFS from entering into 
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the wrong treatment trajectory. To prevent wrong referrals, especially those working in 
intake and screening and those who manage programs need to be well informed. MHCs 
have many employees who work in different locations, so informing everyone is no simple 
task. Ways to inform as many people as possible include on-site presentations at one or 
more locations, and/or including an article about the new treatment and referral options in 
a newsletter for employees.
5. Measure patient symptoms and limitations before and after treatment so that 
treatment outcomes can be made transparent and used for follow-up of referring 
health care professionals.
Treatment of CFS is aimed at recovery-not at learning how to cope with fatigue. In order to 
know whether this goal has been achieved, treatment needs to be evaluated with reliable 
and valid instruments such as the Checklist Individual Strength (for fatigue) [13] and the 
Medical Outcomes Survey Short Form-36 (for impairment) [14, 15]. Dutch norms for the 
scales are available. Evaluation of treatment outcome is also a condition for certification. 
Without evaluation it is impossible to know whether the health care facility is capable of 
effectively treating CFS. More importantly, therapists and patients need to be clear on 
whether (sufficient) improvement has ensued from the intervention. It is useful to share 
this information in the final session with the patient.
Results
What are the experiences with implementation of CBT for CFS in an MHC 
with use of the manual?
Based on the experiences with the 2003 project, a practice project aimed at implementation 
of CBT for CFS commenced in collaboration with three MHCs: ‘GGnet’, ‘GGZ Westelijk 
Noord-Brabant’, and ‘PsyQ Rijnmond’. Over the course of two and a half year, data about 
the treatment of CBT was collected. Health care professionals at ‘GGnet’ wanted to continue 
to use the already implemented treatment. ‘GGZ Westelijk Noord-Brabant’ and ‘PsyQ 
Rijnmond’ implemented CBT for CFS with use of the manual. Each facility was awarded 
a budget to appoint an officer to organise the implementation internally and to ensure 
continuity of care. The role of the specialists in the treatment of CFS was limited to the 
training and supervision of therapists. 
‘GGnet’ was able to carry on their treatment programs at a similar level. The issue of relatively 
high dropout rates of patients during intake and treatment—something that has been 
observed in the earlier implementation—was not solved. This dropout is partly preventable 
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if patients can start immediately with intake and treatment. ‘GGZ Westelijk Noord-Brabant’ 
and ‘PsQ Rijnmond’ both had problems during the first year of the implementation, 
including getting referrals to come in for the new treatment options and problems in final 
stages of treatment. Therefore, half way through the project, more support was offered for 
the continuation of the implementation. Initiatives were made to recruit patients and the 
participating institutions were regularly offered feedback on the process. With this extra 
support, all facilities successfully implemented CBT for CFS. A full description of the results 
can be found in Chapter 6 of this dissertation [16].
The most important lesson learned from this project (i.e., implementation of CBT for CFS 
in collaboration with ‘GGnet’, ‘GGZ Westelijk Noord-Brabant’, and ‘PsyQ Rijnmond’) is that 
MHCs can offer high-end CBT for CFS, providing that there is sufficient external guidance 
from specialists in the treatment of CFS during the first two years. This external guidance 
is crucial to successful implementation additional to preparedness of the institutions to 
invest in the appointment of an officer to support the organisation of the implementation 
internally. During implementation and beyond, treatment outcomes need to be monitored 
in order to ensure quality of care as well as successful implementation. 
Simultaneously with the aforementioned project, the first step in stepped care for CFS—
guided self-instruction with support from a therapist via email—was tested in an MHC (‘GGZ 
Westelijk Noord-Brabant’) (Chapter 4) [17]. In a controlled, randomised trial it was examined 
whether psychiatric nurses, some with limited experience with behavioural therapy, can 
successfully execute the minimal intervention. The results of this trial show that after guided 
self-instruction, patients experienced significantly fewer symptoms related to fatigue. These 
results are as positive as those found in an earlier study in which the minimal intervention 
was guided by behavioural therapists [7]. 
Conclusion
Problems with implementation
Experience has taught us that during implementation, some problems may arise. We will 
describe these here in brief.
Recruiting patients. The number of patients that is referred to a new institution varies and 
depends on communication aimed to disseminate information. It is important that therapists 
treat at least six patients annually in order to gain enough experience for this specific work. 
It is therefore essential that during the initial phases, ample time and attention is dedicated 
to circulating information about the new treatment options. 
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Ending therapy. On average, new therapists treat patients longer than is prescribed in 
the protocol. The long treatment duration is often related to the experience level of the 
therapist, who may also be of the opinion that (further) recovery is still possible after the 
recommended treatment duration. However, long-term treatment (i.e., more than 20 
sessions) is rarely helpful [2]. 
Evaluating treatment and follow-up. Pre- and post-treatment evaluation is not standard in 
all MHCs, but is important in order to gain insight into the success of the implementation. 
Especially a post-treatment evaluation reveals efficacy as well as weaknesses. In addition, 
health care professionals need follow-up regarding the patients they referred: What 
happened to those patients and how did treatment work out? Follow-up will make it more 
likely for referring health care workers to refer new candidates for treatment.
Monitoring and active support. Previous experience taught us that external guidance 
during implementation of a stepped care approach for CFS is crucial during the first two 
years. During this period, extra support needs to be offered, for example in the area of 
evaluation or motivating health care professionals to refer patients. After the first two years, 
institutions are able to carry on the treatment independently and in keeping with quality 
standards. 
Why is national implementation needed?
In the Netherlands, there are many patients with CFS who, due to a lack of treatment capacity, 
cannot receive evidence-based treatment in the area where they live. Implementation 
of a stepped care for CFS in an MHC is possible and appears effective, providing there is 
additional support in the start-up phase. National implementation of stepped care for CFS 
seems a logical next step. 
The relatively high costs for implementation, training, supervision, coordination, information 
dissemination, and maintenance is a barrier to this next step however, and initially, there 
will be a negative balance between investment and return. Depending on insurance 
reimbursements and number of patients, the stepped care program for CFS should be 
profitable within four to six years. Financial support would increase the willingness of MHCs 
to implement these treatments. In addition, CBT for CFS is a cost efficient treatment from 
societal perspective [9, 18]. Annual profits resulting from CBT for CFS are related to the 
decrease in medical consumption (fewer medical tests) and decrease in absenteeism (an 
increase in participation in the work force) are higher than the costs needed to implement 
and execute CBT for CFS. If health care professionals can diagnose CFS and refer patients 
directly to an MHC, then a visit to an internist or neurologist is rarely needed.
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In closing, we argue in favour of implementation of stepped care for CFS. Patients with CFS 
need more treatment options so that they can receive treatment right away, and in their 
own geographical location. The treatments, guided self-instruction, and CBT have proved 
their efficacy. In the national implementation trajectory, therapists will be selected, trained, 
and supervised, to enable them to execute the treatments in the best possible ways. 
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In the second part of the discussion, the results of the studies reported in this thesis will be 
discussed in the light of the literature on diagnosing and treating chronic fatigue syndrome 
(CFS). Possible implications of our findings for the treatment of CFS patients and suggestions 
for future research will be discussed. For this we will follow the patient’s journey from 
diagnosis to treatment. 
Diagnosing CFS in primary care
Fatigue is a common complaint in general practice [1]. Most of the patients with fatigue 
(75%) need only one consultation with their general practitioner (GP), and in 90% of the 
cases the fatigue lasts less than six months [2]. Occasionally, fatigue can become severe and 
interfere with normal life. When a patient presents with persisting and disabling fatigue 
for more than six months, GPs should consider the diagnosis of CFS [3, 4]. CFS is a clinical 
diagnosis made after excluding medical or psychiatric diseases that can explain fatigue. 
Correctly diagnosing CFS is necessary for appropriate referral for treatment. Not diagnosing 
CFS means withholding the patient from the possibility to reduce symptoms and even 
recover.
 
The NICE guidelines recommend that a diagnosis of CFS should be made in primary care [5, 
6]. In the study described in chapter 2, we found a large discrepancy between the number 
of patients that might be considered as having CFS in primary care and the number of 
patients who were actually diagnosed as CFS. Others also showed that CFS is more common 
in primary care than recognised by the GP [7-9]. In a cross-sectional random sample of the 
adult female population in Nijmegen [9], more than 70% of the CFS-like group consulted 
their GP because of fatigue. Only 6 out of the 89 CFS-like subjects (6.7%), were actually 
diagnosed as having CFS. This indicates that CFS is under diagnosed.
Why does under diagnosis occur? Several reasons can be mentioned. GPs have limited 
knowledge about CFS [10, 11]. In a study performed in the Netherlands, more than 25% of 
the GPs reported they did not know how to diagnose CFS. In their opinion a medical specialist 
should diagnose CFS. GPs themselves often felt they were unable to adequately inform a 
CFS patient about the illness and the treatment options [11]. In the UK—before the NICE 
guidelines for CFS appeared—nearly half of the GPs reported lack of confidence in making a 
diagnosis of CFS [10]. Also more recent studies showed that GPs feel uncomfortable making 
a diagnosis of CFS [12, 13]. 
 
It is also known that some GPs have negative attitudes and scepticism towards CFS [14, 15]. 
Bowen et al. reported that in a UK primary care study 28% of the GPs did not accept CFS as a 
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clinical entity [10]. Negative attitudes towards CFS exist because the lack of a precise bodily 
location, reclassification of CFS over time, and doctor-patients miscommunications about 
causes and management [14]. In a qualitative study some GPs expressed the concern that 
a label of CFS can cause harm to the patient. The GPs felt there was no clear management 
pathway for either the GP or the patient [12]. These perceptions may be a barrier to effective 
illness management.
GPs as the gatekeepers of healthcare, apply a generalistic approach. If a person presents 
with fatigue, generalists exclude the presence of (chronic) diseases. They suggest that their 
role—in making a diagnosis of CFS—is to exclude physical causes for the patient’s symptoms 
[12]. At the same time they try to understand the complaint in the context of the patient: the 
context–oriented approach. In the absence of a somatic disease, generalists try to explain 
fatigue as a consequence of what is happening in the patient’s life. Therefore, generalists 
often assume that fatigue is a sign of psychosocial problems. Moreover, generalists are 
often reluctant to pay attention to somatic symptoms assumed to be part of psychosocial 
problems. This is similar to what we found in chapter 2. GPs saw fatigue as a symptom of 
psychosocial and psychiatric problems and therefore did not diagnose CFS. They considered 
the psychosocial problem as the central issue and expected that attention for somatic 
aspects of complaints would impede the solution of these problems. However, the presence 
of psychological problems is not an exclusion criterion for CFS, as long as fatigue is the main 
complaint [4, 16]. By focusing on the psychosocial problems, the generalist might withhold 
the patient from an effective intervention, i.e. CBT aimed at the cognitions and behaviour 
that perpetuate the fatigue.
Another possible explanation of under diagnosis of CFS might be found in the interaction 
between the GP and the patient. We found inconsistency between what patients reported to 
have mentioned during the consultation and what was registered in the electronic medical 
file (chapter 2). Potential barriers include the complexity of patients’ problems and patients’ 
judgements about how to manage their presentation of CFS [17]. As a result there may be 
some dissimilarity between the patients’ complaints and what is presented. It is unknown 
what exactly happened during the consultations in the investigated general practice, as we 
did not record them. 
How to improve diagnosis of CFS and prevent under diagnosis? It is necessary to convince 
GPs of the usefulness to diagnose CFS. GPs have to feel confident making the diagnosis, 
followed by a referral to an appropriate treatment. Our research group showed that GPs 
informed about CFS reported more positive attitudes towards CFS than non-informed GPs. 
Also, this study showed that GPs who did visit an information meeting about CFS referred 
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significantly more patients for treatment compared to GPs who did not visit the meeting 
[11]. This indicates that GPs referral behaviour can be influenced by written and oral 
information. Another way to reduce under diagnosis is that GPs use an instrument to detect 
CFS. This instrument should be simple and easy to use in clinical practice. A possibility is a 
short questionnaire—with dichotomous answers—that will help GPs to classify a person 
presenting with fatigue as CFS or non-CFS. This instrument should be tested in case studies, 
as it seems that GPs are more easily to convince by this kind of studies than by randomised 
controlled trials (RCTs) [18]. Additional, developing interactive training sessions on how 
to diagnose CFS—introduced in the medical curriculum of GPs—may help GPs to feel 
more confident to diagnose CFS. These training sessions can be based on the guidelines 
for CFS. Recently, the Dutch Institute for Healthcare Improvement (CBO) has developed a 
multidisciplinary guidelines on CFS (www.diliguide.nl/document/3435). The CBO guidelines 
suggest that the GP should consider a diagnosis of CFS if the patient fulfils the criteria for 
CFS without necessarily consulting a medical specialist for additional tests. Guidelines can 
help GPs to optimise the diagnosis and management of CFS and can make GPs more aware 
of treatment options and their effectiveness. 
Minimal CBT interventions 
Benett–Levy et al. (2010) developed a definition of minimal CBT interventions: “The primary 
purpose of minimal intensity CBT is to increase access to evidence-based psychological 
therapies in order to enhance mental health and wellbeing on a community-wide basis, 
using the minimum level of intervention necessary to create the maximum gain [19].” Three 
types of support in minimal intensity interventions can be distinguished: self-administered, 
minimal contact and guided self-help [20, 21]. In self-administered interventions support 
in the use of self-help is provided at any time with contact restricted to the research 
team regarding non-process issues. Patients who follow a minimal contact intervention 
are provided with a rationale for the use of the materials, which also may include regular 
contact regarding process but without any focus on process issues. During guided self-help 
interventions patients receive an initial support session in which the rationale is explained. 
During this session the patients receives material they can work through independently, 
while a therapist has contact with the patient at regular times to discuss progress and 
process issues [20, 21]. 
Efficacy of minimal CBT interventions for CFS
It is shown that minimal interventions can affect symptom report in (chronic) diseases [22-
26]. This is also demonstrated for CFS [27-30] (Chapter 4) [31]. The table below gives an 
overview of the effects found in RCTs of minimal interventions for CFS (Table 1.) A study of 
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Chalder et al. was not included as this study investigated the effect of a self-help treatment 
for patients with chronic fatigue (not CFS) [32]. 
In summary, all studies showed that minimal interventions for CFS are effective in reducing 
fatigue. Some remarks can be made when comparing the studies. In three studies the 
intervention was carried out by cognitive behaviour therapists, whereas the other two 
studies selected nurses to guide the intervention. Wearden et al. [29] used the intervention 
described and carried out by Powell et al. [27] in a primary care setting, and found that 
pragmatic rehabilitation—as this intervention was called—was less effective compared to 
the previous trial. Therapist variations could be a possible explanation for this finding. In 
the first trial [27] the therapy was delivered by one very experienced therapist, who had 
developed the treatment. In the trial of Wearden et al. general nurses who had no previous 
experience with pragmatic rehabilitation or counselling for CFS were trained to carry out the 
therapy [29]. Although these nurses showed to be competent, the effect sizes were smaller. 
In our trial, chapter 4 [31], we showed that psychiatric nurses—novice with respect to CBT 
and the treatment of CFS but experienced in counselling—can be trained to deliver the 
minimal intervention effectively. Effect sizes for fatigue were similar compared to the trial 
where patients received support from experienced cognitive behaviour therapists [28, 31]. 
Also some other possible explanations for the dissimilarity between the studies of Wearden 
et al. and Powell. et al. and our studies can be mentioned [27-31]. First, Wearden et al. 
included more severely affected patients compared to the trial of Powell et al. [27, 29]. We 
did not find differences in the characteristics of the patients between our two trials [28, 
31]. Second, delivering the treatment in patients’ homes causes different barriers compared 
to delivering the therapy in a healthcare setting [27, 29]. Our interventions, guided self-
instruction, were carried out by patients at home, but guided by email contacts between 
patient and therapist [28, 31].
Only three of the five studies reported follow-up effects [27, 29, 30]. The studies performed 
in our centre [28, 31] could not assess follow-up effects. In both studies patients were offered 
regular CBT if the minimal intervention did not lead to the desired effect. As a consequence 
measuring follow-up effects will lead to bias, as only follow-up effects after successful guided 
self-instruction can be collected. The other studies showed contradictory follow-up effects. 
Improvement of fatigue and physical functioning after telephone CBT was maintained at one 
year follow-up [30]. Also Powell et al. reported that positive effects were maintained at one 
year follow-up [27]. This in contrast with the study of Wearden et al. who did not find that 
post-treatment results maintained at follow-up [29]. In order to be an alternative to regular 
CBT, treatment effects should be sustained over time as is the case with regular CBT [33, 34]. 
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There seem to be differences in effect between minimal interventions providing support by 
mail and minimal interventions providing support by telephone. Burgess et al. compared 
face-to-face CBT with telephone CBT for CFS [30]. They showed that telephone CBT is 
non inferior to face-to-face CBT (Table 1). This is not what we found when comparing the 
minimal intervention with regular CBT (Chapter 3) [35]. The percentage of patients with 
clinically significant improvement after guided self-instruction, 27% [28], was considerably 
less than after regular CBT, 48% (Chapter 3) [35], indicating that regular CBT is more effective 
in reducing fatigue than guided self-instruction. It would be useful to compare effect sizes 
of both interventions, but this is impossible because the lack of a control group receiving 
no treatment in the study of Burgess et al. [30]. Percentages of clinical improvement are 
mentioned, but different criteria are used and therefore not comparable. Additionally, 
it has to be mentioned that total therapist time during telephone CBT (526 minutes) is 
substantial higher compared to guided self-instruction (316 minutes). The same goes for the 
percentage of dropout, respectively 36% and 7%. The considerably percentage of dropouts 
may question the findings of Burgess et al. as this study performed a complete case analysis 
instead of an intention-to-treat analysis as we did in our study. 
Telephone and email support differ in their advantages and opportunities for patients. During 
a telephone call, the patient receives immediate feedback in response to his input. Additional 
questions can be asked when the received feedback is not clear or not sufficient. On the other 
hand, communication by email is slower and consequently easier to follow. The patient has 
the opportunity to reread the feedback. In addition, email is available at any time. As a result 
telephone and email support may serve different needs and preferences. It is quite conceivable 
that patients with CFS prefer (and need) immediate feedback to change their behaviour. 
Through the development of communication tools, as for example Skype and Face Talk, 
immediate feedback during internet treatment of CFS seems implementable in the near future. 
Finally, it is unclear how much support is necessary for a reduction of fatigue. There is 
a considerable variation in total therapist time (range: 246 – 683 minutes) between the 
studies presented in Table 1. Insufficient data were presented to compare the influence 
of level of support. Powell et al. and Burgess et al. did study the effect of different levels 
of support within their study. In both studies, no differences in effect were found for the 
diverse levels of support [27, 30]. None of the minimal interventions for CFS examined if 
a self-administered intervention (without support of a therapist) can lead to a significant 
reduction of fatigue and disabilities. For depression, several studies tested whether a 
minimal intervention without therapist support is effective. Some studies found positive 
effects of support [25, 36], whereas others didn’t [37, 38]. For minimal interventions for CFS 
the impact of support is unknown. Future studies should focus on this issue.
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Predictors and moderators of treatment outcome
Several studies investigated predictive and moderating factors of treatment outcome 
in patients with CFS [34, 39-47]. A predictor or moderator is a variable that can predict 
outcome, for example reduction of fatigue. Only one study investigated predictors of 
treatment outcome in minimal interventions for CFS [28]. It was showed that a subgroup 
of patients with high levels of fatigue and disabilities profited less from the minimal 
intervention [28], suggesting that patients with very severe symptoms could perhaps 
better directly be referred to regular CBT. In chapter 5 we showed that patients with 
stronger avoidance of activities and patients with more severe depressive symptoms do 
not benefit as much from the minimal intervention as those who have low tendency to 
avoid activity and those who do not have severe depressive symptoms. Patients with 
clinically relevant depressive symptoms may have better treatment outcomes if they are 
directly referred to CBT, as depressive symptoms do not seem to predict outcome in regular 
CBT [45]. Additionally patients’ expectations at the start of CBT for CFS seem predictive 
of treatment outcome [48]. Patients with very positive outcome expectations had a larger 
reduction in fatigue than patients with less positive expectations. It is likely this also applies 
to the minimal intervention. Therapists need to pay attention to the patients’ beliefs and 
expectations of the minimal intervention they offer. Future research should focus to assess 
patients’ suitability for the minimal intervention. By identifying predictors and moderators 
of treatment outcomes it can be determined which patients can best be directly referred 
to CBT and which patients should be offered a minimal intervention. In this way treatment 
efficacy and efficiency can be enhanced.
Mechanisms of change
Although minimal interventions for CFS are effective in reducing fatigue and disabilities, 
little is known about the specific mechanisms of change. Mediation analyses are a way to 
obtain insight in the process in which a variable intervenes in the relationship between 
treatment and outcome [49, 50]. Wiborg et al. [51] used a structural equation model to 
test whether changes in focusing on symptoms, perceived problems with activity, and 
sense of control over fatigue mediated the effect in a minimal intervention of CFS [28] for 
fatigue and disabilities. Mediation analysis showed that a decrease in perceived problems 
with activity and an increase in sense of control of fatigue contributed to the treatment 
effect of the minimal intervention for CFS [51]. In other words change of perception and 
beliefs of activity and fatigue in minimal interventions for CFS is necessary for effectiveness. 
Future research must replicate these findings in order to validate the treatment model. Also 
changes in other factors as for example self-efficacy with respect to activity, catastrophising 
and sleep-wake disruption have to be investigated to test whether they also mediate the 
effect in a minimal intervention. 
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Table 1. Overview of minimal interventions for CFS
Randomisation
Description of the content of the 
intervention
Level of
support
Powell et al. (2001) [27]
Standardised medical care (SDM) (n = 34)
Minimum intervention (MIN) (n = 37)
Telephone intervention (TEL) (n = 39)
Maximum intervention (MAX)(n = 38)
The interventions groups all received 
an educational pack describing the role 
of disrupted physiological regulation 
in fatigue symptoms and encouraging 
home based graded exercise. 
Minimal 
contact
Knoop et al. (2008) [28]
Guided self-instruction (GSI) (n = 85)
Waiting list condition (WLC) (n = 86)
GSI consisted of a self-help booklet 
containing information about CFS and 
assignments combined with email 
contact.
Guided 
self-help
Wearden et al. (2010) [29]
Pragmatic rehabilitation (PR) (n = 95)
Supportive listening (SL) (n = 101)
GP treatment as usual (GP) (n = 100)
PR: similar to the interventions of 
Powell et al. (2001). Level of support 
was different.
SL: provided emotional support.
Minimal 
contact
Burgess et al. (2012) [30]
Face to face CBT (FCBT) (n = 35) 
Telephone CBT (TCBT) 
(n = 45)
FCBT: regular CBT for CFS.
TCBT: patients received a folder 
containing a treatment manual, 
activity, sleep and thought diaries to 
complete. 
Guided 
self-help
Tummers et al. (2012) Chapter 4 [31]
Guided self-instruction (GSI) (n = 62)
Waiting list condition (WLC) (n = 61)
GSI: similar to the intervention of 
Knoop et al. (2008).
Guided 
self-help
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Table 1. Overview of minimal interventions for CFS (continued)
Mean total
therapist
time (min)
Therapist
Effect of the intervention 
on fatigue and physical 
functioning
Percentage 
of drop-out
(%)
Follow-up 
effects
Powell et al. (2001) [27]
MIN: 246
TEL: 452
MAX: 683 
Duration: 
3 months
1 CBT therapist Significant reduction of 
fatigue and increase of 
physical functioning. 
No differences between 
intervention groups.
SDM: 5
MIN: 14
TEL: 18
MAX: 18
Maintained 
at 1 year 
follow-up
Knoop et al. (2008) [28]
GSI: 316
WCL: 120
Duration: 
≥16 weeks
6 CBT therapists 
trained in CBT 
for CFS
Significant decrease 
in fatigue and physical 
disabilities.
GSI: 7
WLC: 5
unknown
Wearden et al. (2010) [29]
PR: 600
SL: 600
Duration: 
20 weeks
3 general 
nurses, received 
training and 
supervision
PR: significant reduction 
in fatigue not in physical 
functioning
 SL: poorer physical 
functioning and no 
difference in fatigue 
PR: 11
SL: 4 
GP: 8
Not 
maintained 
at 70 
weeks 
follow-up
Burgess et al. (2012) [30]
FCBT: 787
TCBT: 526
Duration: 
unknown
8 trained CBT 
therapists who 
had worked at 
the department 
for at least 6 
months 
Significant reductions 
in fatigue and physical 
functioning. No significant 
differences between the 
interventions. 
FCBT: 17
TCBT: 36
Maintained 
at 1 year 
follow-up
Tummers et al. (2012) Chapter 4 [31]
GSI: 276
WLC: 30
Duration: 
≥16 weeks
8 trained 
psychiatric 
nurses, received 
training and 
supervision
Significant decrease in 
fatigue. No significant 
difference in physical 
functioning.
GSI: 11
WLC: 8
unknown
120 Chapter 7
Further development of a model of stepped care for CFS
In a model of stepped care, different levels of care can be offered to the patient, with the 
aim of delivering the least care necessary to treat a patient adequately. At this moment 
the model of stepped care for CFS distinguishes three levels. As a first step, guided self-
instruction can be offered to the patient. Additional the patient can receive CBT delivered 
at a mental health centre (MHC). Next, as a third step, patients who do not recover can be 
referred to specialised treatment settings, as the Expert Centre for Chronic Fatigue. Only 
the first two steps are tested and evaluated. Later, other steps can be added. For example, 
personalised medicine can be introduced based on patients’ preferences or characteristics 
that make a patient likely to profit from an intervention. The first step could be offering 
a self-instruction booklet, for instance by internet, without support of a therapist. If this 
treatment does not have the desired effect or if patients do not want this type of minimal 
intervention without professional help, the next step can be offered: self-instruction with 
support (guided self-instruction). Further development of a model of stepped care means 
formulating criteria to determine when a patient goes on to the next step. For example, 
for some patients it will be immediately clear that the first step, guided self-instruction for 
CFS without face-to-face contact with a therapist, will be insufficient. In that case patients 
need to be directly referred to the second step, regular CBT for CFS. At this moment the 
indications for assignment to a specific step are: (1) the patient does not want guided self-
instruction; (2) the impairment in daily life is extreme; and (3) presence of severe depressive 
symptoms. For the moderator avoidance of activity it is difficult to establish a strict cut-off 
point for assignment to a specific step. 
Barriers and facilitators of implementation
Despite comprehensive research to barriers and facilitators of implementation, there is a 
gap between controlled scientific trials and daily clinical practice [52-54]. Many treatments 
have been tested in RCTs, but only a few have been examined in clinical practice. The barriers 
and facilitators of implementation for treatment for CFS have been discussed in Part I. 
Only three studies evaluated the efficacy of implementation of CBT for CFS in clinical 
practice settings [55-57] (chapter 6). Quarmby et al. compared the treatment results of an 
RCT to clinical routine outcomes of a specialised treatment centre. Between baseline and 
follow-up measurement (six months), the RCT showed greater effect sizes than treatment 
in routine practice [55]. Scheeres et al. (2008) performed an implementation of CBT for CFS 
in an MHC. Intention-to-treat effects were compared to the outcome of four RCTs of CBT for 
CFS. Outcomes of the implementation study did meet the benchmark. In other words, the 
results showed that CBT for CFS can be effectively implemented in an MHC [56]. The latest 
implementation study is described in chapter 6 [57].
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Implementation of stepped care for CFS
The study described in chapter 3, is the first study so far that evaluated a model of stepped 
care for CFS. It showed that stepped care for CFS is as effective as regular CBT, while it is 
more time efficient for the therapist (chapter 3) [35]. In chapter 6 it is illustrated that one 
of the MHC’s implemented CBT in the context of stepped care for CFS. This MHC showed 
significantly lower effect sizes than the effect sizes of a statistical benchmark [56, 57]. While 
in the other MHC’s all patients received regular CBT, in this MHC 50% of the patients had 
received the minimal intervention before they started with CBT. A possible explanation for 
the lower effect sizes is that additional CBT after unsuccessful treatment requires different 
skills from the therapist compared to delivering regular CBT. After unsuccessful treatment 
it is not necessary to follow the complete protocol. Patients require additional support for 
specific elements of the treatment. As a consequence the role of the therapists changes, they 
have to attune more to the specific needs of the patient. Therefore in a next implementation 
project we recommend first to start with implementation of regular CBT. After one year of 
experience with regular CBT, therapists can be trained in the minimal intervention. At this 
point therapist will have gained the skills and knowledge to carry out ‘additional’ CBT after 
an unsuccessful minimal intervention. 
Wiborg et al. found some evidence for a therapist effect. This means that some therapists 
have better results than others [58]. Less favourable attitudes of therapists towards the 
use of treatment manuals predicted less effective treatments. However, the setting where 
the treatment was delivered could also explain the variation in therapist efficacy, as less 
favourable attitudes and less effective treatments were within the same treatment setting. 
Additionally, it has to be mentioned that this MHC was the only MHC who implemented CBT 
in the context of stepped care [58], suggesting the implementation scenario may affect the 
results. 
The third step in a model of stepped care for CFS, referring patients to a specialised tertiary 
treatment setting, has not yet been systematically examined. In the implementation study, 
described in chapter 6 [57], all patients who did not benefit from treatment had the option 
to receive additional treatment in a specialised setting. Only a few patients were actually 
referred. When investigating the reasons behind this, most therapists did not ask their non-
responders if they preferred additional treatment. Due the limit number of referrals it is 
impossible to draw conclusions. Future research should also address this issue. 
Cost effectiveness of implementation
If decision makers want to judge whether implementation of stepped for CFS is advisable, 
they need, besides information about the effectiveness of stepped care, information about 
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the costs and benefits. Several studies have examined the cost-effectiveness of behavioural 
treatments for chronic fatigue and CFS [59-62]. Results were not complete univocal but 
indicate that CBT for chronic fatigue or CFS might be cost-effective for society compared to 
care as usual. From a healthcare perspective the cost outcome ratio was more costly but 
also more effective than before. The proportion of the positive cost outcome ratio depended 
on how much value was placed on a recovered CFS patient. An explorative calculation of 
implementation of stepped care in an MHC showed that after a period of initial investment 
stepped care for CFS is cost effective for an MHC [63]. These data suggest, that implementing 
stepped care CFS in an MHC is cost-effective. 
National implementation of stepped care for CFS
Our research group developed a plan for nationwide implementation of CBT for CFS. The 
plan provided a gradually implementation of stepped care for CFS. First, therapists will be 
trained in regular CBT for CFS. After finishing the training therapists receive supervisory 
sessions for at least one year. Additional, national education meetings will be organised 
twice a year. During the first two years each setting will receive additional support to 
stimulate recruitment of patients, contact with general practitioners and medical specialist, 
and publications in local newspapers. Also the support will include monthly feedback 
about the monitoring data. At each setting a person will be trained to supervise his/her 
colleagues. The aim is that each setting will be able to continue treatment of CBT for CFS 
after the implementation project. Second, after one year, therapists will be trained to carry 
out the minimal intervention. An internet based version of the minimal intervention will be 
developed, implemented and tested on efficacy. 
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Chronic fatigue syndrome (CFS) is characterised by severe and medically unexplained fatigue, 
lasting at least six months and leading to functional impairments in daily life. Other symptoms 
of CFS include non-restorative sleep, post-exertion malaise, headaches, muscle pain, multi-
joint pain, sore throat, tender lymph nodes, and impaired concentration or memory. 
Cognitive behaviour therapy (CBT) for CFS is an effective treatment. CBT is aimed at changing 
fatigue related cognitions and behaviours. CBT for CFS is developed in specialised treatment 
facilities. Previous research has shown that CBT for CFS can be successfully implemented in 
a mental health care centre (MHC). However, wider implementation is hampered by the fact 
that CBT for CFS is an intensive treatment, requiring licensed cognitive behaviour therapists. 
Therefore treatment capacity in the Netherlands is limited and treatment facilities cannot 
meet the demand for CBT for CFS. The studies described in this dissertation increase our 
knowledge about how to increase treatment capacity for CFS (chapter 3-6). The problem of 
under diagnosis of CFS by general practitioners is investigated in chapter 2. 
In chapter 1 a general introduction to CFS and the presented studies is given. Chapter 2 
describes a cohort study in a general practice. It investigated to what extent CFS is diagnosed 
by general practitioners (GPs). Patients visiting the practice in a period of four weeks were 
asked to complete a fatigue questionnaire. In addition, patients who had presented fatigue as 
main complaint one year ago were approached and asked to fill out the same questionnaire. 
Almost a third of the patients visiting their GP reported fatigue. Of the patients presenting 
complaints of fatigue one year ago, 50% still reported fatigue. In the prospective cohort, 
2% (18/500) of the patients fulfilled the US Centers for Disease Control and Prevention 
criteria for CFS based on their response to the questionnaire. In the retrospective cohort, 
8% (19/111) of the patients could be classified as CFS on the basis of the questionnaire. Only 
one person was actually diagnosed by the GP as having CFS. The results of this study suggest 
that GPs have difficulties in diagnosing CFS. There is a discrepancy between the number of 
patients that might be considered as suffering from CFS and the actual number of patients 
that is diagnosed with CFS. This discrepancy is suggestive for under diagnosis of CFS, leading 
to withholding effective treatment from patients. Based on the information in the electronic 
medical files, GPs often interpret fatigue as a symptom caused by psychosocial problems. 
They expect that attention limited to the somatic aspects of fatigue, hinders the solution 
of the psychosocial problems. The data of our study shows that it is necessary to develop a 
model of support for GPs. This can be achieved by providing instruments to assess CFS and 
training of GPs how to diagnose CFS .
There is evidence that not all CFS patients need an intensive CBT intervention. For a 
subgroup of patients, a minimal intervention suffices. This makes it possible to develop a 
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model of stepped care for CFS. In stepped care, more intensive treatments are reserved for 
patients who do not benefit from simpler low-intensity treatments. The model of stepped 
care for CFS distinguishes two levels. As a first step, guided self-instruction is offered to the 
patient. Next, as a second step, the patient receives face to face CBT. Chapter 3 describes 
a randomised noninferiority study which tested the effectiveness and efficiency of stepped 
care for CFS. A total of 171 CFS patients are randomly allocated to stepped care or care as 
usual. Care as usual encompassed CBT after a waiting period. An intention to treat analysis 
showed no significant differences between the two interventions. Both conditions were 
equivalent in reducing fatigue severity and disabilities, and increasing physical functioning. 
When guided self-instruction was not sufficient, fewer sessions of CBT were required in 
subsequent treatment. The total therapist time needed to treat a patient was significantly 
less in the stepped care condition compared with care as usual. It is concluded that stepped 
care is as effective as CBT and more time-efficient.
As mentioned, treatment capacity for CFS is lacking. A minimal intervention based on CBT for 
CFS, guided self-instruction, is shown to be effective when delivered at a tertiary treatment 
facility with guidance of qualified cognitive behavioural therapists. Implementing guided self-
instruction in a community-based MHC will increase the treatment capacity for CFS patients. 
Chapter 4 evaluates the effectiveness of guided self-instruction for CFS implemented in an 
MHC. In a randomised controlled trial it is assessed whether psychiatric nurses, novices 
with respect to CBT and the treatment of CFS, are able to deliver this treatment successfully. 
Patients are randomly assigned to either guided self-instruction or a waiting list. Primary 
outcome variables–fatigue severity and physical and social functioning–are assessed at 
baseline and directly following the waiting period or intervention. After six months, patients 
who followed guided self-instruction reported a significantly larger decrease in fatigue 
compared to the waiting list. There were no significant differences in physical and social 
functioning. A subgroup of patients with physical disabilities at baseline showed a significant 
decrease in both fatigue and physical functioning following the intervention. Controlled 
effect sizes for fatigue severity and physical functioning were similar to those in the previous 
trial testing the effectiveness of guided self-instruction for CFS. To conclude, the results of 
this study suggest that guided self-instruction for CFS, delivered by trained and supervised 
psychiatric nurses, can be implemented successfully in an MHC.
The efficacy of guided self-instruction can be enhanced if it is known which patients will 
benefit from the intervention. This will also increase the efficiency of the treatment. The 
study described in chapter 5 is aimed to identify moderators of the treatment response. 
Moderators are variables that strengthen or weaken the response to treatment. Potential 
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moderators are selected from the literature. To identify whether the selected variables 
moderated the effect of the intervention on fatigue at post-treatment assessment, linear 
and logistic regression analyses are used to test for significant interactions. Data obtained 
from two randomised controlled trials–evaluating the efficacy of guided self-instruction for 
CFS–are combined to test the potential moderators. Patients who were younger, had lower 
levels of depressive symptoms, and who had a lower tendency to avoid activity benefited 
more from the intervention than older patients and patients with higher levels of depressive 
symptoms and a stronger tendency to avoid symptoms. Guided self-instruction is exclusively 
aimed at cognitions and behaviours that perpetuate fatigue. Patients with severe depressive 
symptoms may need more specific interventions aimed at the reduction of these depressive 
symptoms in order to profit from guided self-instruction. Therefore we suggest that patients 
with substantial depressive symptoms be directly referred to regular CBT. 
Besides the development of a model of stepped care for CFS, implementation of guided 
self-instruction in an MHC and the identification of moderators of treatment response, 
wider implementation of regular CBT for CFS can increase the treatment capacity. Chapter 
6 focuses on the treatment effect of CBT of CFS after implementation in three MHCs. We 
evaluated whether community based MHCs are able to implement or sustain CBT for CFS 
with the help of an implementation manual. The MHC that wanted to continue to use 
CBT, was able to carry on the treatment effectively. The other two MHCs had problems 
with the implementation of CBT for CFS. Therefore additional support by experts in CFS 
was needed. Implementation success was defined as including at least 40 patients for the 
treatment program of whom more than 30 had to complete a post-treatment assessment. 
Patients outcomes are documented with validated questionnaires for fatigue and physical 
functioning. With additional support, all MHCs were able to fulfill the success criteria. The 
treatment effects were similar to those found in randomised controlled trials testing the 
efficacy of CBT. Only the MHC which implemented CBT in the context of stepped care, 
showed lower treatment effects that the treatment effects found in the other trials. The 
most important lesson learned from this project is that MHCs can effectively treat CFS with 
CBT providing that there is sufficient support from specialists in the treatment of CFS. 
The general discussion, chapter 7, considers the consequences of the findings of the previous 
chapters for the treatment for CFS. In Part I of the discussion the practical implications of 
the findings are discussed. Part II describes how the findings relate to the literature on 
CFS. The discussion ends with a plan for national implementation of stepped care for CFS. 
According to this plan the patient first receives guided self-instruction, if necessary followed 
by additional face to face CBT. National implementation of stepped care for CFS means that 
CFS patients will receive adequate treatment in their own region.
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Het chronisch vermoeidheidssyndroom (CVS) wordt gekenmerkt door lichamelijk 
onverklaarde ernstige vermoeidheid die langer dan 6 maanden aanhoudt. De vermoeidheid 
leidt tot substantiële beperkingen in het dagelijks leven. Vaak hebben CVS patiënten naast 
vermoeidheid ook andere klachten zoals spierpijn, gewrichtspijn, hoofdpijn, slaapklachten 
en concentratie- of geheugenproblemen. Cognitieve gedragstherapie (CGT) is een 
behandeling voor CVS waarvan de effectiviteit is aangetoond. De behandeling is gericht 
op het veranderen van opvattingen en gedrag die de vermoeidheid in stand houden. CGT 
voor CVS is ontwikkeld in gespecialiseerde behandelcentra. Eerder onderzoek liet zien dat 
CGT voor CVS succesvol in een GGZ-instelling geïmplementeerd kan worden. Idealiter zou 
men deze implementatie uitbreiden, maar doordat CGT voor CVS een intensieve therapie is, 
waarvoor getrainde cognitief gedragstherapeuten nodig zijn, is dit lastig te realiseren. Mede 
hierdoor is de behandelcapaciteit in Nederland niet toereikend. De vraag naar CGT voor 
CVS is groter dan het aanbod. De studies die in dit proefschrift worden beschreven dragen 
bij aan de kennis over hoe we de behandelcapaciteit kunnen uitbreiden (hoofdstuk 3 t/m 
6). Het probleem van onderdiagnostiek van CVS in de huisartsenpraktijk is onderzocht in 
hoofdstuk 2.
 
In hoofdstuk 1 wordt een inleiding gegeven over CVS en worden de achtergronden van 
de beschreven studies besproken. Hoofdstuk 2 beschrijft een cohort studie, uitgevoerd in 
een huisartsenpraktijk. Het doel van deze studie was om vast te stellen of huisartsen de 
diagnose CVS stellen bij patiënten die hiervoor in aanmerking komen. Gedurende 4 weken 
is aan alle spreekuurbezoekers gevraagd een korte vragenlijst over vermoeidheid in te 
vullen. Daarnaast zijn patiënten die een jaar eerder de huisartsenpraktijk hadden bezocht 
met als primaire klacht vermoeidheid, aangeschreven met het verzoek dezelfde vragenlijst 
in te vullen. Bijna een derde van de spreekuurbezoekers gaf aan vermoeid te zijn. Van de 
patiënten die een jaar eerder last hadden van vermoeidheid, had 50% dit nog steeds. In 
het prospectieve cohort voldeed 2% (18/500) van de spreekuurbezoekers aan de consensus 
criteria van het US Centre for Disease Control voor CVS. In het retrospectieve cohort gold dit 
voor 8% (19/111) van de patiënten. Slechts één patiënt was daadwerkelijk gediagnosticeerd 
als CVS. Deze resultaten laten zien dat huisartsen minder vaak dan verwacht, op grond 
van de klachten van de patiënten, de diagnose CVS stellen. Het verschil tussen het aantal 
patiënten dat is gediagnosticeerd en het aantal patiënten waarbij die diagnose had 
moeten worden gesteld kan duiden op het onderdiagnosticeren van CVS hetgeen leidt tot 
onderbehandeling. Op grond van de informatie in het medisch dossier bleken huisartsen 
vermoeidheid vaak als een onderdeel van psychosociale problematiek te interpreteren 
in plaats van als een op zichzelf staande klacht. Aandacht voor de (somatische aspecten 
van) vermoeidheid, zou het aanpakken van de psychosociale problemen hinderen. Het is 
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nodig huisartsen hulpmiddelen te verschaffen zodat zij wanneer dat gerechtvaardigd is de 
diagnose CVS kunnen stellen. Door het ontwikkelen van meetinstrumenten om CVS vast te 
stellen en huisartsen te trainen in het stellen van de diagnose CVS kan de diagnostiek van dit 
syndroom in de huisartsenpraktijk worden verbeterd. 
Eerder onderzoek heeft laten zien dat niet alle CVS patiënten een intensieve cognitieve 
gedragstherapie nodig hebben. Een aantal patiënten heeft aan een minimale interventie 
al genoeg. Vanuit deze bevinding is een model van getrapte zorg voor CVS ontwikkeld. In 
een model van getrapte zorg krijgen patiënten een intensievere behandeling aangeboden, 
als een minder intensieve behandeling niet geslaagd is of als vooraf al duidelijk is dat zij 
daar niet van zullen profiteren. Getrapte zorg voor CVS bestaat uit (1) zelfbehandeling met 
e-mail ondersteuning, zonodig aangevuld met (2) individuele reguliere CGT. Hoofdstuk 
3 beschrijft de uitkomsten van een gerandomiseerde gecontroleerde studie naar de 
effectiviteit en efficiëntie van getrapte zorg voor CVS. Patiënten met CVS (n = 171) werden 
willekeurig toegewezen aan ofwel getrapte zorg ofwel reguliere zorg. Reguliere zorg 
bestond uit CGT na een wachtperiode. Een intention-to-treat-analyse liet geen significante 
verschillen zien tussen de twee interventies. Beide leiden tot een significante afname van 
vermoeidheidsklachten en beperkingen. Als zelfbehandeling, de eerste stap van getrapte 
zorg voor CVS, niet het gewenste resultaat opleverde, hadden patiënten minder sessies 
individuele CGT nodig om alsnog te profiteren van behandeling. Ook was de tijd die een 
therapeut nodig had om een patiënt te behandelen met getrapte zorg significant minder 
dan tijdens reguliere zorg. Getrapte zorg voor CVS is dus even effectief als CGT, maar wel 
efficiënter.
De behandelcapaciteit van CGT voor CVS is niet toereikend. Onderzoek heeft aangetoond 
dat zelfbehandeling, begeleid door cognitieve gedragstherapeuten en uitgevoerd in een 
specialistisch centrum, leidt tot een afname van vermoeidheidsklachten en beperkingen 
in vergelijking met een wachtlijst. Als het mogelijk is om zelfbehandeling te implementeren 
in andere zorginstellingen, kan de behandelcapaciteit substantieel toenemen. Hoofdstuk 4 
beschrijft de resultaten van een implementatieproject waarin zelfbehandeling, een minimale 
interventie, werd geïmplementeerd en op effectiviteit getoetst in een GGZ-instelling. In 
een gecontroleerde en gerandomiseerde studie werd nagegaan of sociaal psychiatrisch 
verpleegkundigen, waarvan sommigen met beperkte gedragstherapeutische ervaring, in 
staat zijn de minimale interventie met succes uit te voeren. Patiënten werden toegewezen 
aan zelfbehandeling of werden geplaatst op een wachtlijst. De primaire uitkomstmaten, 
ernst van vermoeidheid en ernst van fysieke en sociale beperkingen, werden voorafgaand 
en na afloop van de interventie en de wachtperiode gemeten. Na 6 maanden waren 
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patiënten die de interventie hadden gevolgd significant minder moe dan de patiënten in de 
wachtlijst conditie. Wat betreft fysieke en sociale beperkingen werden er geen significante 
verschillen gevonden tussen de twee condities. Echter, patiënten die voorafgaand aan de 
interventie last hadden van fysieke beperkingen rapporteerden zowel verbetering van 
vermoeidheid als vermindering van beperkingen. De gevonden effecten zijn vergelijkbaar 
met de eerder genoemde studie waarin de zelfbehandeling werd begeleid door cognitieve 
gedragstherapeuten. Onze conclusie is dat de minimale interventie uitgevoerd door 
getrainde en gesuperviseerde sociaal psychiatrisch verpleegkundigen geïmplementeerd kan 
worden in de GGZ.
De effectiviteit van zelfbehandeling voor CVS kan vergroot worden als we weten welke 
patiënten de meeste kans hebben om te profiteren van de behandeling. De behandeling wordt 
hiermee ook efficiënter. De studie beschreven in Hoofdstuk 5 richt zich op het voorspellen 
van behandeluitkomsten na zelfbehandeling door het identificeren van moderatoren. 
Een moderator is een variabele die de richting en de sterkte van de behandeluitkomst 
voorspelt. Potentiële moderatoren van zelfbehandeling voor CVS werden geselecteerd op 
basis van de literatuur. Vervolgens werd met behulp van regressie analyses getoetst of deze 
variabelen het effect van zelfbehandeling konden voorspellen. Om dit te evalueren werden 
de gegevens van twee gerandomiseerde gecontroleerde studies waarin de effectiviteit 
van zelfbehandeling werd getoetst, samengevoegd. Patiënten met CVS die jonger waren, 
minder last hadden van depressieve symptomen of minder geneigd waren om activiteiten 
te vermijden, behaalden betere uitkomsten na behandeling. Zelfbehandeling is uitsluitend 
gericht op opvattingen en gedragingen die de vermoeidheid in stand houden. Patiënten 
met ernstige depressieve symptomen hebben mogelijk specifieke interventies nodig gericht 
op het verminderen van de depressieve symptomen om te kunnen profiteren van de 
interventie. Ons advies is daarom om patiënten met ernstige depressieve symptomen direct 
reguliere CGT aan te bieden.
Naast het ontwikkelen van getrapte zorg, de implementatie van zelfbehandeling in een 
GGZ-instelling en het identificeren van patiënten die de grootste kans hebben om te 
profiteren van zelfbehandeling, kan uitbreiding van het reguliere CGT aanbod ook zorgen 
voor een toename van de behandelcapaciteit. Hoofdstuk 6 beschrijft de behandelresultaten 
van CGT voor CVS bij implementatie in drie GGZ-instellingen. Bij één instelling was de 
vraag of zij de reeds geïmplementeerde behandeling op een vergelijkbaar niveau zonder 
hulp konden voortzetten. De overige twee instellingen hadden CGT voor CVS zelfstandig 
geïmplementeerd aan de hand van een handleiding. De eerste instelling was in staat het 
zorgaanbod op een vergelijkbaar niveau uit te voeren, de andere twee instellingen hadden 
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problemen met de implementatie van CGT voor CVS. Extra ondersteuning van deskundigen 
bleek noodzakelijk. De vooraf vastgestelde succescriteria voor implementatie, het werven 
van tenminste 40 patiënten waarvan 30 of meer de behandeling hadden afgerond (inclusief 
nameting), werden mede door de extra begeleiding door alle drie de instellingen behaald. 
De behandeluitkomsten werden voor en na de behandeling gemeten met gevalideerde 
vragenlijsten voor vermoeidheid en beperkingen. De effectiviteit van de behandeling in de 
GGZ instellingen kwam overeen met die van CGT voor CVS in eerdere gerandomiseerde 
studies. De instelling waarbij naast reguliere CGT gelijktijdig de minimale interventie werd 
geïmplementeerd, had minder gunstige resultaten na behandeling dan de overige twee 
instellingen. Het belangrijkste leerpunt van dit praktijkproject is dat GGZ-instellingen in staat 
zijn om CGT voor CVS zelfstandig op een kwalitatief hoog niveau aan te bieden, mits er bij 
de start voldoende ondersteuning aanwezig is door specialisten in de behandeling van CVS. 
In hoofdstuk 7 worden de resultaten uit de voorgaande studies bediscussieerd. In het 
eerste deel van de discussie worden de praktische implicaties van de studies besproken. 
In het tweede deel van de discussie zijn de resultaten van de studies vergeleken met de 
internationale literatuur over diagnostiek en behandeling van CVS. De discussie wordt 
afgesloten met een plan voor landelijke implementatie van getrapte zorg voor CVS. In 
dit model ontvangt een patiënt met CVS eerst de minimale interventie, zonodig gevolgd 
door individuele CGT. Het is wenselijk om dit model van getrapte zorg voor CVS landelijk te 
implementeren, zodat het straks voor iedere CVS patiënt mogelijk is om in zijn of haar regio 
een effectieve behandeling te ontvangen. 
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Misschien is het je al opgevallen dat er in dit proefschrift verschillende bloemen staan. 
Waarom? Omdat ik vind dat een bloem een goede metafoor is voor mijn promotietraject. 
Op de eerste plaats staat de bloem symbool voor de patiënten, die hopelijk door het volgen 
van de behandeling weer in de bloei van hun leven staan. Ten tweede staat de bloem 
centraal voor het werk zoals beschreven in dit proefschrift. Het zaadje ‘implementatie 
van behandeling voor CVS’ dat we gepland hebben is uitgegroeid tot een prachtige tulp 
‘behandeling voor iedereen in zijn of haar omgeving’. Maar het belangrijkste symbool waar 
de bloem voor staat is dat de bloem alleen kan groeien en bloeien door verzorging, aandacht 
en liefde. Ik ben de mensen om mij heen dankbaar voor de zorg, aandacht en liefde die ik 
tijdens het schrijven van dit proefschrift heb mogen ontvangen. Een aantal mensen wil ik in 
het bijzonder bedanken.
Gijs Bleijenberg en Hans Knoop
Mijn promotor en copromotor. Gijs, toen wij elkaar in 2007 voor het eerst ontmoetten had 
ik nooit gedacht dat dit proefschrift het uiteindelijke resultaat zou zijn. Voor jou was dat 
echter al snel duidelijk, te concluderen uit het feit dat je mij na ons tweede gesprek een 
baan aanbood. Ik heb de afgelopen jaren veel van je geleerd. De belangrijkste vaardigheden 
zijn misschien wel ‘blijf kritisch’, ‘groot denken’ en ‘onderbouw je keuzes’. Drie dingen waar 
ik nog dagelijks de vruchten van pluk. Hans, samen met Gijs vorm jij de stabiele begeleiding 
die je als promovendus wenst. Je hebt me geleerd om niet te verzanden in details, maar 
me te richten op de grote lijn. Ik wil je danken voor je vertrouwen, op het moment dat er 
tegenslagen waren was jij altijd in staat om te relativeren en de positieve kanten te belichten.
Patiënten, therapeuten en sociaal psychiatrisch verpleegkundigen
Wat betreft de organisatie waren sommige onderzoeken een behoorlijke klus, maar het 
meeste en zwaarste werk is verricht in de praktijk. Van sommige patiënten weet ik dat 
vermoeidheid en de daarbij behorende beperkingen niet langer meer een issue zijn. Voor de 
anderen hoop ik dat deelname aan de onderzoeken iets heeft opgeleverd, al is het misschien 
niet het gewenste resultaat. Dank voor jullie inzet. Ook de therapeuten van het Nijmeegs 
Kenniscentrum Chronische Vermoeidheid (Annemarie, Gerrie, Hans, Hein, Henriëtte en 
Thea) en de sociaal psychiatrisch verpleegkundigen van de GGZ Westelijk Noord-Brabant 
(Anne-Marie, Annette, Claire, Esther, Frans, Karla, Rita en Robert) ben ik veel dank 
verschuldigd. Regelmatig kregen jullie van mij mailtjes en/of telefoontjes met betrekking 
tot gegevens die ontbraken en iedere keer waren jullie weer bereid om het voor mij uit 
te zoeken en erachteraan te gaan. Sociaal psychiatrisch verpleegkundigen voor jullie was 
het terrein van het chronisch vermoeidheidsyndroom en de daarbij behorende behandeling 
onbekend. Ik heb er bewondering voor hoe jullie je de behandeling hebben eigen gemaakt 
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en er kleur aan hebben gegeven. Het resultaat hiervan is terug te zien in het aantal herstelde 
patiënten. Tevens wil ik de therapeuten werkzaam bij GGZ Westelijk Noord-Brabant, PsyQ 
Den Haag en GGnet bedanken voor hun inzet en het behandelen van patiënten.
Mede auteurs
Peter Lucassen, Arno van Dam en Michel Wensing, dank voor jullie waardevolle bijdrage 
aan de artikelen in dit proefschrift. Arno, zonder jouw betrokkenheid en inzet bij de 
implementatie van zelfbehandeling in de GGZ Westelijk Noord-Brabant hadden we niet de 
successen behaald, zoals te lezen in hoofdstuk 4. Je enthousiasme waarmee je knelpunten 
hebt aangepakt, hebben ertoe geleid dat zelfbehandeling nu een vast onderdeel is van 
jullie behandelaanbod: een prachtig resultaat. Rogier Donders, dank dat ik altijd bij je kon 
aankloppen voor allerlei statistische vragen. Op lastige vragen van de reviewers had jij altijd 
een gepast antwoord klaar.
Leden van de manuscriptcommissie
Jan Smit, Sandra van Dulmen en Giel Hutschemaekers, dank voor de tijd en moeite die 
jullie hebben genomen om mijn manuscript te lezen en te beoordelen.
Collega’s van het nijmeegs kenniscentrum chronische vermoeidheid
Jullie zijn al die jaren dat ik werkzaam was bij het NKCV ontzettend belangrijk geweest 
voor mijn werkplezier! Gesprekken over koetjes en kalfjes, mooie momenten en soms 
ook verdrietige momenten, wandelingen in het park, het zingen van verjaardagsliedjes, de 
vrijdagmiddagborrel en al die andere dingen, maken dat het ik fijn vond om deel uit te 
maken van het team. Ellis, Liesbeth en Thea, hoe zou het NKCV reilen en zeilen zonder de 
‘drie musketiers’? Jullie houden het NKCV draaiende, dank doorvoor! Carel, Judith, Lianne 
en Tiny, zonder jullie hulp ben je als onderzoeker nergens. Ook al kwamen jullie om in het 
werk, nooit was iets teveel gevraagd. Bedankt ook aan alle therapeuten (Agaat, Annemarie, 
Anthonie, Dennis, Hans, Hein, Henriëtte, Inge, José en José, Pauline, Suzanne en Thea). 
Natuurlijk enerzijds voor de vele onderzoeken waaraan jullie een bijdrage hebben geleverd, 
maar vooral voor de gezelligheid. Dames (Marianne, Marieke en Martine) hadden wij even 
geluk dat we door de ballotagecommissie kwamen op selectie van onze voornamen. Samen 
met Jan hebben we heel wat uurtjes in ‘kamer 4’ doorgebracht. Doordat we allemaal min of 
meer in hetzelfde schuitje zaten konden we dingen met elkaar delen en samen stressen voor 
het maandagochtend overleg. Dank voor al jullie adviezen en tips en niet werkgerelateerde 
praatjes en uitjes, want die dingen zorgen ervoor dat het hebben van kamergenoten een 
toegevoegde waarde heeft!
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Lieve vriendinnen en vrienden
Een promotietraject zonder met enige regelmaat heerlijk te ontspannen met vriendinnen en 
vrienden zou ik niemand aanraden. Sommige van jullie zaten (zitten) in hetzelfde schuitje, 
voor anderen staat promoveren heel ver af van jullie eigen werkzaamheden/interesses. Jullie 
waren altijd bereid om mijn verhalen aan te horen en de promotieperikelen van een andere 
kant te bekijken. Het heeft me vaak geholpen om dingen in perspectief te plaatsen. Dank 
voor jullie trouwe vriendschap en ik hoop dat we nog veel gezellige, leuke, fijne momenten 
samen mogen beleven. Babette, voor jou een speciaal woordje van dank! Dankzij jou ziet 
dit proefschrift er zo prachtig uit. Je wilt niet weten hoe ik trots ik ben dat jij de kaft van dit 
proefschrift voor me hebt willen tekenen.
 
Laura en Ellen, lieve meiden
Vriendinnetjes door dik en dun. Lieve Ellen, we leerden elkaar kennen tijdens de allereerste 
werkgroep en vanaf het begin was er de spreekwoordelijke ‘klik’. We zien elkaar misschien 
nu iets minder dan we af en toe zouden willen, maar wat mij betreft doet dat niets af aan 
onze vriendschap! Lieve Laura, alles kan ik met je delen. Waar ik ook ben, wat er ook is, je 
staat altijd voor me klaar (ondanks dat er thuis een kleine dame rondloopt en er een tweede 
op komst is). Lieve meiden, ik vind het ontzettend fijn dat jullie vandaag mijn paranimfen 
zijn. Bedankt voor alle mooie momenten die we samen hebben beleefd (en die nog gaan 
komen)!
Lieve Mam, Pap en Joep
Jullie zijn voor een groot deel verantwoordelijk voor de basis van dit proefschrift. Mam en 
pap, jullie hebben me altijd gestimuleerd om mijn beste beentje voor te zetten, de uitkomst 
was van ondergeschikt belang. Iedere keer als we elkaar zagen vroegen jullie vol interesse 
naar de voortgang van het proefschrift. Nu kan ik zeggen ‘het is klaar’. Dank voor al jullie 
goede zorgen en onvoorwaardelijke steun! Joep, dit laatste geldt natuurlijk ook voor jou. 
Hoewel onze interesses van elkaar verschillen, sta je altijd voor me klaar. Dank daarvoor. Je 
bent een fijn broertje!
Lief
Lieve Coos, ik wil je bedanken voor Coos te zijn: zoals je bent en vooral er altijd voor me 
bent. Regelmatig propeer ik 48 uur in één dag te proppen. Op die momenten weet jij mij 
altijd met beide benen terug op de grond te zetten en te zorgen voor rust. Het is fijn om 
samen met jou tegenslagen te relativeren en successen te vieren. Dank voor alles. Ik vind 
je lief!
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